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 Manganese (Mn) neurotoxicity has been recognized for a long time and it  
 
affects primarily the basal ganglia.  However, only recently has inflammation, which is  
 
known to play an important role in neuropathology, been considered as part of its  
 
toxic mechanism.  In the current study, we have shown that Mn-potentiation of  
 
inflammatory cytokines ( IL-6 and TNF-α) in microglia is not dependent on the activation  
 
of the Toll-like receptor (TLR)-4 signaling pathway by lipopolysaccharide (LPS), as  
 
potentiation by Mn is observed in microglia activated with agonists for other TLR, such  
 
as TLR2, TLR3, and TLR9.  Furthermore, enhancement of inflammatory cytokine  
 
production by Mn is independent of the MyD88 signaling pathway, as Mn-potentiation  
 
 




 Additionally, inhibition of p38, ERK, or JNK mitogen-activated protein  
 
kinases (MAPK) prevented Mn-potentiation, which suggest that these MAPK are  
 
required for potentiation of inflammatory cytokines by Mn.  We also observed that Mn  
 
exposure results in persistent activation of p38.  The prolonged activation of p38 may be  
 
due to increased activation of the ‘upstream’ MAPK, mitogen-activated protein kinase  
 
kinase (MKK)-1/2 or MKK-4, or to decreased expression of the phosphatase, mitogen- 
 
activated protein kinase phosphatase-1 (MKP-1), that is responsible for deactivating p38. 
 
 Overall, it appears that Mn potentiates microglial inflammatory cytokine output 
 
in conjunction with diverse stimuli by an unknown mechanism, but likely involving  
 
MAPK and perhaps extending their activation, that of p38 in particular.  This ability of  
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Overview of metal toxicity 
 
 The use of metals has been an important facet of human society since the end of 
the Stone Age of man.  From tools for agriculture to weapons of war, metals have been 
applied to many uses, including therapeutics for ailments and disease.  Indeed, it is 
perhaps the medicinal uses that first illustrated the toxicity that could occur from 
prolonged or excessive metal exposures (Koehler, 2001).  Metal organ system toxicities 
include adverse effects of cadmium on the endocrine and renal systems (Fowler, 1993; 
Henson and Chedrese, 2004), and those of chromium on the hepatic, renal, and 
respiratory systems (Wedeen and Qian, 1991).  Of the organ system toxicities that 
excessive metal exposure can manifest itself with, it is perhaps the nervous system that is 
most sensitive.  Metal neurotoxicity has been documented and studied for several metals, 
including copper (Cu), iron (Fe), manganese (Mn), mercury (Hg) and lead (Pb; 
Gutteridge, 1992; Stankiewicz et al., 2007; White et al., 2007; Wright and Baccarelli, 
2007).  Generally, the mechanism(s) of toxicity for these metals includes either binding 
to cellular proteins (i.e. Hg and Pb), or induction of oxidative stress within the exposed 
tissue (i.e. Cu, Fe, and Mn; Stankiewicz et al., 2007; Wright and Baccarelli, 2007).  It is 
the ability of transitions metals, like Mn, to promote oxidative stress within the nervous 
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system that has become an area of research, as CNS oxidative stress may be important in 
the initiation of neurological diseases such as Parkinson’s Disease (Dobson et al., 2004).  
 
Essentiality, routes of exposure, and bioavailability of manganese 
 
In modern times, Mn is encountered in mining and the smelting of metals, alloy 
industry, as a component of the fuel additive methylcyclopentadienyl manganese 
tricarbonyl (MMT), and in pesticides such as manganese ethylene bisdithiocarbamate 
(Maneb; Frumkin and Solomon, 1997; Aschner, 2000).  Additionally, Mn is an essential 
dietary component and trace amounts are necessary for many physiological processes 
including synthesis of amino acids, lipids, proteins, and carbohydrates (Finley and Davis, 
1999).  Toxicologically, oral exposure to Mn is not a major route of exposure due to the 
low concentrations found in most foods and the limited transport by the gastrointestinal 
system (1-5%; Davidsson et al., 1988; Davis et al., 1993).  Although parenteral nutrition 
may increase the exposure risk to Mn, typically this form of nutritional intake is only 
performed in controlled medical settings and on a limited basis (Wright and Baccarelli, 
2007).  Other potential routes of Mn exposure include the skin, a relatively impermeable 
barrier to charged particles, and the respiratory system.  The absorption of Mn by the 
olfactory nerve and lungs is largely dependent on particle solubility (MnSO4>Mn3-
(PO4)4) and  this route of exposure, in terms of neurotoxicity, is toxicologically relevant 
(Roels et al., 1997; Dorman et al., 2001).  Significant concentrations of Mn in the air can 
be found near industries involved in ferroalloy production, iron and steel foundries, and 
from power plant emissions (Lioy, 1983).  Indeed, processing of Mn-containing ores 
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resulted in the first recorded Mn-caused neurotoxicity (reviewed by Aschner and 
Aschner, 1991). 
 
Manganese toxicity and manganism 
In 1837 ore grinders exposed to Mn dust exhibited extrapyramidal dysfunction 
with neuropsychiatric symptomatology referred to as “locura manganica” or 
“manganism” (reviewed by Aschner and Aschner, 1991). The overall effect of Mn on the 
central nervous system (CNS) is still not well understood. However, it has been 
demonstrated that Mn-induced neuropathology is similar to another neurological disorder 
of unknown etiology, Parkinson’s Disease (PD).  The study of this neurological disease 
has, in part, furthered our understanding of Mn neurotoxicity. 
 
Parkinson’s disease 
In the early 19th century, the English physician James Parkinson described a 
shaking palsy in several patients (reviewed by Kempster et al., 2007). This disease would 
later come to bear his name.  Although little progress was made in understanding PD over 
the next 100 years, the Swedish neuroscientist, Arvid Carlsson, proposed in the 1960’s 
that PD was the result of damage to the dopaminergic neurons in a region of the midbrain 
responsible for coordinating voluntary movement (Carlsson, 2001).  This hypothesis was 
later shown to be correct and successful treatments were devised including the use of L-
Dopa, one of the precursors necessary for the synthesis of dopamine (Carlsson, 2001).  
The study of PD has demonstrated the sensitivity of the dopamine-producing neurons to 
stressors, particularly oxidative stress (Dobson et al., 2004; HaMai and Bondy, 2004).   
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In fact, as discussed below, it is oxidative stress that is thought to be partially responsible 
for the direct effects of Mn on dopaminergic neurons (Dobson et al., 2004; HaMai and 
Bondy, 2004).  
 
Mechanisms of manganese neurotoxicity 
The sensitivity of dopaminergic neurons to Mn is partially attributed to the ability 
of Mn to interact with the catechols, such as dopamine and its precursors/metabolites, 
leading to their oxidation and generation of the reactive intermediates, and, ultimately, 
cell death (Graham et al., 1978; Donaldson et al., 1982; Archibald and Tyree, 1987; 
Sistrunk et al., 2007).  Alternatively, Mn has been shown to exert toxicity on neurons by 
directly disrupting neuronal mitochondrial respiration, leading to decreased ATP 
production and oxidative stress (Aschner and Aschner, 1991; Gavin et al., 1999).  This is 
supported by studies demonstrating that Mn-containing compounds, such as the fungicide 
Maneb and the fuel additive MMT, can inhibit mitochondrial respiration (Autissier et al., 
1977; Zhang et al., 2003).  Perturbation of mitochondrial function apparently is not 
limited to dopaminergic neurons as other neuronal types, e.g. striatal GABA interneurons 
are affected by Mn exposure (Liu et al., 2006). 
These effects are, in part, attributed to transport mechanisms that favor the influx, 
but not the efflux, of Mn into the mitochondria (Gunter et al., 1994; HaMai and Bondy, 
2004).  Although research examining the ability of Mn, or other stressors, to directly 
damage neurons has been conducted, another potential target for Mn-induced 




Inflammation and manganese 
In the CNS, both astroglia and microglia are found in close proximity to neuronal 
cells.   However, while astrocytes are uniformly distributed throughout the brain, 
microglial cells are not. In fact, areas of the brain affected by Mn, such as the striatum 
and the substantia nigra have more microglia than areas that appear to be less affected, 
i.e., brain stem and cerebellum (Lawson et al., 1990; Savchenko et al., 2000). 
 Recent publications have demonstrated the ability of Mn to stimulate, or 
augment, the ability of glial cells to produce inflammatory mediators that can damage 
surrounding neuronal cells.   Astroglia, for example, accumulate Mn and can produce 
reactive oxygen species (ROS) and other substances that may be damaging to neurons 
(Aschner, 2000).  Microglia are producers of several key inflammatory cytokines, such as 
TNF-α, and they are the major producers of this cytokine in the CNS (Kim and de Vellis, 
2005).  Moreover, as stated, it has been demonstrated that microglia and/or astroglia 
produce inflammatory mediators and microglia-derived mediators can stimulate 
astrocytes, thus creating a vicious inflammatory cycle.  Such inflammatory cycle may be 
involved in the mechanisms of Mn neurotoxicity, especially in cases where an additional 
inflammatory stimulus leads to the activation of glial cells (Chang and Liu, 1999; Filipov 
et al., 2005; Spranger et al., 1998).  
Due to the ability of microglial cells to process antigen for presentation to other 
cells of the immune system, as well as their ability to produce a diverse array of 
cytokines and immunological factors, microglia are considered the primary immune 
effector cells of the CNS (Perry et al., 1998; Kreutzberg, 1996; Kim and de Vellis, 2005).  
Thus, it is possible that at least part of the Mn-induced neuronal toxicity is the result of 
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inappropriate, or inopportune, activation of the microglial cells, leading to enhanced and 
prolonged synthesis of inflammatory mediators and ensuing neuronal damage. 
Activation of microglial cells may also occur as a consequence of neuronal cell 
damage or death.  The release of neuronal cellular components like heat shock proteins 
and ATP have been shown to activate microglial cells (Kakimura et al., 2002; Shimizu et 
al., 2005; Potucek et al., 2006; Light et al., 2006).  Alternatively, infection of the CNS by 
viral agents such as vesicular stomatitis virus and HIV has been shown to induce the 
(primarily) microglial production of inflammatory molecules such as nitric oxide (NO) 
and cytokines directly (Epstein and Gelbard, 1999).  Additionally, systemic infection or 
peripheral inflammogen administration can activate CNS microglia, an effect of 
significant consequence in the presence of active neurodegeneration (Cunningham et al., 
2005), particularly in the aged (Godbout et al., 2005).  On the other hand, activation of 
microglia can occur in the absence of infection. Exposure to the model PD toxicant, 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is associated with microglial 
activation (McGeer et al., 2003).  Indeed, it is the potential for microglial activation by 
the previously listed mechanisms that explains the use of microglial activators, such as 
MPTP and bacterial lipopolysaccharide (LPS), in experimental models of PD or Mn 
neurotoxicity. 
 
Microglia and Parkinson’s Disease-like neuropathology 
Early studies examining the role of microglia in PD-like neurotoxicity utilized the 
model PD toxicant MPTP.  In both human and animal exposures to MPTP, prolonged 
activation of microglial cells was demonstrated long after exposure to MPTP had ended 
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(McGeer et al., 2003).  Additionally, it has been demonstrated that prior exposure to Mn 
before challenge with MPTP will result in greater basal ganglia pathology than exposure 
to Mn or MPTP alone (Takahashi et al., 1989).   
Since exposure to MPTP has been largely limited to i.v. drug users and laboratory 
animals, the relevance of this exposure model in the context of co-exposure to Mn 
becomes questionable.  Although MPTP is a potent activator of microglia, a more 
relevant microglial activator may be lipopolysaccharide (LPS), a cell-wall component of 
Gram-negative bacteria.  LPS is a common environmental contaminant and model 
inflammogen due to its ability to stimulate microglia to produce cytokines, NO, and ROS 
(Chao et al., 1992; Jeohn et al., 2002b; Liu et al., 2002).  Indeed, binding of LPS to the 
recently discovered Toll-like Receptor 4 (TLR4) has been shown to be key for activation 
of cells of the innate immune system, including microglia (Bhat et al., 1998; Jeohn et al., 
2002a;  Medzhitov and Janeway, 1997; Takeda and Akira, 2004). 
 
Toll-like receptors, intracellular signaling and inflammation 
The discovery of the Toll-like receptor (TLR) family of proteins fundamentally 
changed the perceived role of the innate immune system.  Interestingly, the initial finding 
that led to the discovery of the TLR family of proteins was not the result of 
experimentation in a typical animal model of innate immunity, rodent (mouse or rat), but 
in the developmental biology of the fruit fly, Drosophila melanogaster.  Indeed, it was 
the discovery of the molecule Toll, which is required for the development of dorsal-
ventral polarity in the fruit fly embryo, as well as fly immune responses to fungal 
pathogens, that led to the discovery of the TLR family of proteins (Anderson et al., 1985; 
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Hashimoto et al., 1988; Lemaitre et al., 1996; Takeda and Akira, 2004; Beutler, 2004).  
Importantly, the discovery of the TLR molecules demonstrated that innate immune 
responses are not merely primitive and nonspecific, but are surprisingly complex and 
highly specific (Beutler, 2004; Takeda and Akira, 2004).  Moreover, it has been 
suggested that TLR-mediated innate immunity is not only the first line of defense against 
invading pathogens, but that TLR are,  possibly, the most important receptors in initiating 
both innate and adaptive immune responses (Beutler, 2004). 
Although it is the recognition of pathogen-associated molecular patterns (PAMP) 
such as Gram negative bacterial LPS, viral RNA (polyinosinic:polycytidylic acid; pI:C), 
viral DNA (Cytosine Guanine linear dinucleotide; CpG), or Gram positive bacterial 
peptidoglycan (peptidoglycan from Staphylococcus aureus; GPG) by their TLR (TLR4, 
TLR3, TLR2, and TLR9, respectively) that initiate innate immunity and inflammation, it 
is the intracellular signal transduction pathways that control the expression/production of 
immune and inflammatory mediators (Beutler, 2004; Takeda and Akira, 2004).  
Generally speaking, TLR intracellular signaling is a series of activation events linking the 
TLR to adaptor molecules such as myeloid differentiation primary-response protein 88 
(MyD88) or Toll-receptor-associated activator of interferon (TRIF), which subsequently 
activate primary kinases (Interleukin-1-receptor-associated kinase [IRAK], transforming 
growth factor-β activating kinase-1 [TAB1], TNF-receptor-associated factor 6 [TRAF6] 
or TRAF-family-member-associated NF-kB activator-binding kinase 1 [TBK1], and 
secondary signaling kinases Mitogen activated protein kinases; [MAPK]). Ultimately, 
these events lead to the activation of one or more transcription factors such as NF-kB, 
activator protein-1 (AP-1), or signal transducer and activator of transcription I (STAT I) 
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that induce inflammatory mediator mRNA expression and, in the case of inflammatory 
cytokines, subsequent protein production and release (Beutler, 2004; Takeda and Akira, 
2004). 
The specific signaling molecules induced by TLR-PAMP interaction are 
dependent on the TLR.  For instance, TLR3-mediated intracellular signaling is 
independent of MyD88, instead requiring TRIF for initiation of intracellular signaling 
(Beutler, 2004; Kawai and Akira, 2006).  In contrast, TLR2, TLR4, and TLR9 induce 
signaling via MyD88 (Beutler, 2004; Takeda and Akira, 2004).  However, only TLR2 
and TLR9 are entirely dependent on MyD88, as TLR4 can initiate intracellular signaling 
by both MyD88-dependent and MyD88-independent (i.e. TRIF) pathways (Beutler, 2004; 
Takeda and Akira, 2004).  For MyD88-dependent signaling, activation of the primary 
kinases, including IRAK, TRAF6 and TAK1, leads to the activation of the MAPK and 
NF-kB, while TRIF (MyD88-independent) signaling activates TBK and IRF3, leading to 
the activation of the STAT I transcription factor (Beutler, 2004; Takeda and Akira, 2004).   
Although TLR-induced intracellular signaling has been examined for several 
TLRs, the key role of TLR in both cellular innate immunity and inflammation is perhaps 
best illustrated by the first TLR-PAMP to be described, TLR4-LPS.  Indeed, it was the 
observation that C3H/HeJ and C57BL/10ScCr mouse strains are resistant to LPS-induced 
endotoxic shock, but susceptible to gram negative bacterial infection (e.g. LPS-
containing bacteria), that led to the discovery of TLR4 as the receptor for LPS (Poltorak 
et al., 1998).  Typically, binding of LPS to TLR4 leads to the association of the MyD88 
adaptor protein (Figure 1-1).  Subsequently, MyD88 recruits IRAK-1 and IRAK-4, 
serine-threonine kinases that phosphorylate TRAF6 (Beutler, 2004; Figure 1-1).   
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Activation of TRAF6 by IRAK-1/4 leads to the activation of the MAP3K TAK-1, leading 

































Figure 1-1 LPS signaling via the TLR4 receptor. 
 
Figured adapted from Beutler (2004).  Abbreviations: TLR (Toll-like receptors), MyD88 
(myeloid differentiation factor 88), Mal/TIRAP (MyD88-Toll/Interluekin-1 receptor 
region adaptor protein), TRAM (Toll-receptor-associated molecule), TRIF (Toll-
receptor-associated activator of interferon), IRAK (Interleukin-1 receptor-associated 
receptor kinase), TRAF (TNF-receptor-associated factor), TAK1 (Transforming-growth-
factor-β-activated kinase), TAB (TAK1-binding protein), TBK (TRAF-family-member-
associated NF-kB activator-binding kinase), IRF3 (Interferon-regulatory factor 3), IKK-
(Inhibitor of nuclear factor-kB-kinase complex), NF-kB (nuclear factor-kB), MAPK 
(Mitogen-activated protein kinase), ERK (Extracellular regulated kinase), JNK (c-JUN n-
terminal kinase), TBP (TATA-binding protein). 
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Once activated, TAK-1 phosphorylates the MAP2K (i.e. MEK-1/2, MEK-3/6, and  
 
MEK-4) which phosphorylate the MAPK, resulting in the initiation of cellular processes,  
 
including gene transcription (Seger and Krebs, 1995; Koistinaho and Koistinaho, 2002;  
 
Figure 1-2).  The MAPK are composed of the extracellular signal-regulated kinases  
 
(ERK), stress-activated or c-Jun N-terminal kinases (SAPK/JNK), big MAPK 1 (BMK1),  
 
and the p38 MAPK (Seger and Krebs, 1995).  Regulation of the MAPK cascade occurs  
 
by activation by ‘upstream’ MAP2K, as well as dephosphorylation of the MAPK due to  
 
the actions of phosphatases, such as the dual specificity phosphatases (DUSP; Camps et  
 
al., 2000).  The DUSP dephosphorylate the MAPK at one or both phosphorylation sites,  
 
leading to the deactivation of the MAPK (Camps et al., 2000). Of these MAPK, p38  
 
MAPK (p38) and ERK appear to be primarily involved in the production of inflammatory  
 



































Figure 1-2 The MAPK Cascade 
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Microglial models of inflammation: mechanisms 
In primary microglia and microglial cell lines, LPS has been shown to dose- and 
time-dependently increase the phosphorylation of ERK, JNK, and p38, as well as 
increase the expression of iNOS, TNF-α, and Cox-2 (Bhat et al., 1998; Lee et al., 1994; 
Lee et al., 1993; Waetzig et al., 2005). However, the p38-dependent increases in NO 
production require not only the phosphorylation of p38 but increased kinase activity as 
well (Jeohn et al., 2002b).  
Additionally, by exposing microglia to ERK- and p38-inhibitors prior to exposure 
to LPS, the LPS-induced increases in NO and TNF-α were inhibited (Bhat et al., 1998).  
Furthermore, LPS-induced, p38-dependent, increases in NO and TNF-α by microglia 
have been shown to decrease neuronal survivability in neuronal-glial co-culture, an effect 
that can be inhibited by pretreatment with inhibitors of p38 (Jeohn et al., 2002b).  
However, TLR expression and inflammatory cytokine production by microglia is not 
limited to TLR4, as microglia express mRNA for TLR 1-9 (Olson and Miller, 2004; Jack 
et al., 2005), with 2, 3, 4, and 9 being the most abundant (Olson and Miller, 2004; Jack et 
al., 2005).  Furthermore, microglia produce IL-6 and TNF-α, as well upregulate cell-
surface molecules such as major histocompatibility complex-II and costimulatory 
molecules including CD-40, CD-45, and CD-11b (Olson and Miller, 2004). 
 
Manganese, microglia, and inflammation 
Although inflammatory responses are essential for the maintenance and defense 
of tissues, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis, 
especially in sensitive tissues such as the nervous system. In fact, abnormally high levels 
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of inflammatory cytokines, such as TNF-α, have been implicated in the etiology of PD 
(Nagatsu et al., 2000). Within the context of Mn neurotoxicity, Mn enhances the 
production of inflammatory mediators by microglia, as exposure to Mn potentiates LPS-
induced production of TNF-α, IL-6 (Filipov et al., 2005) and NO (Chang and Liu, 1999; 
Filipov et al., 2005) in vitro.  Additionally, this effect is NF-kB-dependent as inhibitors 
of NF-kB were able to prevent the potentiation observed in Mn/LPS exposed cells 
(Filipov et al., 2005). 
 
Significance of research and hypothesis 
In previous research, we have demonstrated that Mn-potentiated, LPS-induced 
inflammatory cytokine production by N9 microglia is NF-κB-dependent (Filipov et al., 
2005).  At present, it is not known whether the potentiation of inflammatory cytokines 
and NO production by Mn occurs at the level of NF-kB or further upstream in the 
intracellular signaling cascade.  Since potential ‘upstream’ targets include the MAPK 
family of kinases, it is reasonable to suggest that Mn may act on one, or more, of the 
MAPK.  Moreover, as the MAP2K are responsible for activating the MAPK, while 
phosphatases (i.e. DUSP) deactivate MAPK, it is necessary to examine the role of these 
molecules in the potential activation of the MAPK by Mn exposure.  Furthermore, as 
TLR intracellular signaling is differential, examining Mn-potentiation of microglial 
output of inflammatory mediators in N9 microglia activated by different TLR may 
provide additional data regarding the mechanism of Mn-potentiation.  We hypothesize (i) 
that Mn enhances inflammatory cytokine production by acting on one or more of the 
MAPK molecules, leading to increased phosphorylation and prolonged activation of the 
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MAPK, (ii) if enhanced MAPK activation is observed, either increased MAP2K 
activation or decreased phosphatase activity may be involved, and (iii) enhanced MAPK 
activation may not be specific to TLR4 activation, as Mn may potentiate inflammatory 









MANGANESE POTENTIATION OF IN VITRO PROFINFLAMMATORY CYTOKINE  
 
PRODUCTION BY ACTIVATED MICROGLIAL CELLS IS ASSOCIATED WITH  
 





Previous studies that investigated the role of inflammation in the neurotoxicity of  
 
manganese (Mn) found that Mn enhanced the production of inflammogen 
 
(lipopolysaccharide; LPS)-induced inflammatory cytokines such as IL-6 and TNF-α.   
 
Although we have shown that the enhanced cytokine production occurs via a NF-κB- 
 
dependent mechanism, the role of upstream kinases in this Mn-induced enhancement has  
 
not been explored.   As other studies have demonstrated that p38 mitogen activated  
 
protein kinase (p38) is necessary for LPS-induced, NF-κB-dependent expression of  
 
inflammatory cytokines, we hypothesized that Mn enhancement of LPS-induced  
 
production of IL-6 and TNF-α may be associated with p38 and conducted a series of  
 
experiments to address our hypothesis.  We found that pre-treatment of microglial cells  
 
with a p38-inhibitor (SB203580) prevented Mn+LPS- induced production of IL-6 and  
 
 
1 Reprint with permission (Appendix A) from Crittenden, P. L., and Filipov, N. M. (2008). 
Manganese-induced potentiation of in vitro proinflammatory cytokine production by 
activated microglial cells is associated with persistent activation of p38 MAPK. Toxicol 
In Vitro 22, 18-27. 
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TNF-α.   Moreover, potentiation of IL-6 and TNF-α production, which occurred in both  
 
concurrent and sequential (3 h apart) exposures to Mn and LPS, was inhibited by  
 
inhibition of p38. Additionally, Mn exposure enhanced the phosphorylation and activity  
 
of p38 and this effect was persistent.  Although p38 activity declined over time in vehicle  
 
and LPS-exposed cells, it persisted in cells exposed to Mn or Mn+LPS. Thus, the  
 
increased production of inflammatory cytokines by LPS-activated microglia exposed to  
 




Manganese (Mn), while an essential metal, is also a common environmental 
contaminant.  The presence of Mn in alloys, fertilizers, batteries, and fungicides, as well 
as the re-introduction of the fuel additive methylcyclopentdienyl manganese tricarbonyl 
(MMT), is of environmental and occupational concern (Frumkin and Solomon, 1997; 
Aschner, 2000).  Occupational exposure to Mn has been linked to a specific 
neuropathology, manganism, that is characterized by clinical signs and lesions similar to 
Parkinson’s Disease (PD; Meco et al., 1994).  Manganese is thought to exert its effects, at 
least partially, by disrupting mitochondrial respiration leading to increased oxidative 
stress (Aschner and Aschner, 1991; Gavin et al., 1999).  This is supported by studies 
demonstrating that Mn-containing compounds, such as the fungicide Maneb and the fuel 
additive MMT, can inhibit mitochondrial respiration (Autissier et al., 1977; Zhang et al., 
2003).   
While Mn is directly toxic to neuronal cells, neurons are not the only CNS cells 
that are associated with and contribute to Mn neurotoxicity.  Astrocytes, for example, 
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accumulate Mn and may produce reactive oxygen species (ROS) and other substances 
that may be damaging to neurons (Aschner, 2000).  Importantly, it has been demonstrated 
that the other CNS resident cells, the microglia, and/or the astrocytes may produce 
inflammatory mediators that could be involved in the mechanisms of Mn neurotoxicity, 
especially in cases where an additional inflammatory stimulus is present (Spranger et al., 
1998; Chang and Liu, 1999; Filipov et al., 2005).   
Microglia have been implicated in PD (humans and animal models) and research 
utilizing the model PD toxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)  
has shown that activated microglia persist long after exposure to MPTP has ended 
(McGeer et al., 1987; McGeer et al., 2003).  Additionally, it has been demonstrated that 
prior exposure to Mn before challenge with MPTP will result in greater basal ganglia 
pathology than exposure to Mn or MPTP alone (Takahashi et al., 1989).  Therefore, this 
study suggests that Mn exposure has the potential of interacting with other basal ganglia 
toxicants, thus causing greater neurotoxicity. However, the likelihood of such exposure 
(i.e. Mn + MPTP) is remote.   A more relevant model, however, may involve Mn and 
lipopolysaccharide (LPS).  LPS is a common environmental contaminant (Niehaus and 
Lange, 2003) and model inflammogen due to its ability to stimulate microglia to produce 
cytokines, nitric oxide (NO), and ROS (Chao et al., 1992; Jeohn et al., 2002b; Liu et al., 
2002). Importantly, LPS exposure is also associated with basal ganglia toxicity (Niehaus 
and Lange, 2003) and it has been used as a model for PD (Castano et al., 2002; Liu et al., 
2002)  
Binding of LPS to CD14 and TLR4 cell surface receptors leads to the activation 
of intracellular kinases, including the mitogen activated protein kinases (MAPK; Bhat et 
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al., 1998; Jeohn et al., 2002b).  The MAPK family of proteins is comprised of the 
extracellular signal-regulated kinases (ERK), stress-activated or c-Jun N-terminal kinases 
(SAPK/JNK), big MAPK 1 (BMK1), and the p38 MAPK (Koistinaho and Koistinaho, 
2002).  Of these MAPK, p38 MAPK (p38) and ERK appear to be primarily involved in 
the production of inflammatory mediators by microglia.  In primary microglia and 
microglial cell lines, LPS has been shown to dose- and time-dependently increase the 
phosphorylation of ERK and p38, as well as increase the expression of iNOS and TNF-α 
(Lee et al., 1993; Lee et al., 1994; Bhat et al., 1998). However, the p38-dependent 
increases in NO production require not only the phosphorylation of p38 but increased 
kinase activity as well (Jeohn et al., 2002a). Additionally, by exposing microglia to ERK- 
and p38-inhibitors prior to exposure to LPS, the LPS-induced increases in NO and TNF-
α were inhibited (Bhat et al., 1998).  Furthermore, LPS-induced, p38-dependent, 
increases in NO and TNF-α by microglia have been shown to decrease neuronal 
survivability in neuronal-glial co-culture (Jeohn et al., 2002a; Jeohn et al., 2002b). The 
fact that this effect can be inhibited by pretreatment with inhibitors of p38 suggests that 
p38 appears to play a dominant role in the process.  
Although inflammatory responses are essential for the maintenance and defense 
of tissues, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis, 
especially in sensitive tissues like the nervous system. In fact, abnormally high levels of 
inflammatory cytokines, such as TNF-α, have been implicated in the etiology of PD 
(Nagatsu et al., 2000). Within the context of Mn neurotoxicity, Mn enhances the 
production of inflammatory mediators by microglia.  Indeed, exposure to Mn potentiates 
LPS-induced production of inflammatory cytokines (TNF-α & IL-6) and NO in vitro 
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(Filipov et al., 2005). Additionally, this effect is NF-kB-dependent as inhibitors of NF-kB 
were able to prevent the potentiation observed in Mn+LPS exposed cells (Filipov et al., 
2005).  At present, it is not known whether the potentiation of inflammatory cytokine 
production by Mn occurs at the level of NF-kB or further upstream in the intracellular 
signaling cascade.  Since potential upstream targets include p38 and ERK and because a 
p38 inhibitor alone or in combination with an ERK inhibitor prevents the LPS-induced 
production of inflammatory mediators (Bhat et al., 1998), we conducted preliminary 
studies examining the effect of MAPK inhibition on cytokine production in Mn-exposed 
microglial cells activated with LPS (Crittenden and Filipov, 2004).  From these studies 
we determined that inhibition of p38, but not of ERK, eliminated the potentiation of LPS-
induced cytokine production in N9 microglial cells.  
 After we established the role of p38 in the enhancement of LPS-induced 
inflammatory cytokine production by Mn, our objectives in this study were to (i) examine 
in detail the functional activation of p38 by exposure to Mn by itself or in combination 
with LPS (ii) to evaluate the time-window during the inflammatory cytokine production 
process which is dependent upon p38 in Mn+LPS-exposed microglia. 
 
Materials and Methods 
 
 
 Chemicals.  Unless specified, all chemicals and reagents were purchased from 
Sigma-Aldrich (Sigma; St. Louis, MO) and MnCl2 with purity >99% was used. 
 
 Cell Culture.  The N9 murine microglial cell line used in the experiments was a 
gift kindly provided by Dr. P. Ricciardi-Castagnoli (University of Milan, Italy).  These 
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cells, derived by a retroviral immortalization of day-13 embryonic mouse brain cultures, 
are similar to primary microglia in that, upon activation, they produce inflammatory 
cytokines, such as IL-1β, IL-6, and TNF-α, as well as NO (Righi et al., 1989).   
The cultures were maintained (5% CO2, 95% air, at 37°C) in RPMI-1640 
supplemented with 10% FBS, 0.075% sodium bicarbonate, 1 mM sodium pyruvate, 1 
mM non-essential amino acids, 2 mM L-glutamine, 50 µM 2-mercaptoethanol, 25 µg/ml 
gentamycin, 100 U/ml penicillin G, and 100 mg/ml streptomycin (all from Invitrogen, 
Carlsbad, CA).  For pharmacological inhibition and cytokine studies, cells were seeded at 
0.25 x 106 cells/well (0.5 ml volume) in 48-well plates (Costar; Fisher Scientific, 
Pittsburgh, PA).  For western blot protein analysis, cells were seeded at 2.5 x 106 
cells/well (5 ml volume) in 6-well plates (Costar), whereas for the flow cytometry 
analysis, the density was 2.0 x 106 cells/well (4 ml volume).  Cells were incubated for up 
to 24 h in the presence of Mn (250 µM) and/or LPS (Escherichia coli 055:B5; 
Calbiochem, La Jolla, CA; 100 ng/ml).  
In our preliminary studies (Crittenden and Filipov, 2004), and in Filipov et al., 
(2005), Mn concentrations of 50-1000 µM and LPS of 10-1000 ng/ml were used, and the 
potentiation of cytokine production was both Mn- and LPS-dependent. Hence, the 
concentrations of Mn and LPS used in this study were selected based on previous 
experiments that indicated no significant N9 cell death following exposure to Mn and/or 
LPS at these concentrations (Filipov et al., 2005) and are in line with numerous other in 
vitro studies where levels of Mn (Mn2+) range from 10 µM to 4 mM with the most typical 
exposure range being 100 to 500 µM (Li et al., 2005; Malthankar et al., 2004).  
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Moreover, the above concentrations and the concentrations used in our study are 
representative of Mn levels found in brains of non-human primates following exposure to 
manganese dioxide for 3 months (ranging from 35 to 350 µM; Suzuki et al., 1975). 
Elevated levels of Mn in the basal ganglia are not associated only with occupational 
exposure, but have been also observed in the brains of PD patients, as well as in 
autopsied brains of patients with cirrhosis (Yase, 1972).   Of note, the concentration of 
LPS we have used in the present study (100 ng/ml) is relatively low and we have already 
reported that when greater amounts of LPS are present in the culture medium, less Mn is 
required for a potentiating effect on cytokine production to be observed (Filipov et al., 
2005). 
 
Cytokine Analysis.  The amounts of interleukin-6 (IL-6) and tumor necrosis  
factor-α (TNF-α) in the supernatants were determined using DuoSet ELISA kits (R&D; 
Systems, Inc., Minneapolis, MN) as per manufacturer’s instructions. Briefly, 96-well 
microplates (Costar) were coated with 1:180 dilution of respective capture antibody in 
PBS and incubated overnight at room temperature (RT). The plates were then washed 
with PBS-Tween buffer (3x) and blocked (1% BSA, 5% sucrose in PBS) for 1 h at RT.  
Next, plates were washed again (3x) and either samples or standards were dispensed into 
the wells.  After incubating for 2 h at RT the plates were washed (3x), incubated with 
detection antibody for 2 h, and washed again (3x).  Strepavidin-HRP conjugate was then 
added for 20 min, plates were washed (3x), and TMB-based substrate was added to each 
well and allowed to develop up to 30 min.  The reaction was stopped by addition of 50 µl 
of 2N H2SO4 per well and the absorbance was read using a Spectramax Plate Reader 
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(Molecular Devices, Sunnyvale, CA) at 450 nm. All samples for each cytokine were 
assayed in duplicate, and the mean was used in the subsequent statistical analysis.  A 
standard curve was generated for each plate. 
 
 Pharmacological manipulations. The p38 inhibitor, SB203580 (Calbiochem, 
San Diego, CA), was added 3 h prior to, or after, the addition of Mn, LPS, or Mn and 
LPS to the cell culture.  The inhibitor was dissolved in DMSO (26.5 mM) and stored at –
80°C until diluted to a working concentration (50 µM) prior to use. The final DMSO 
concentration was < 0.2% for vehicle and p38-inhibitor exposed cells. 
 
  Immunoblot analysis of p38 and phospho-p38.  After incubation for 15 min, 1 
and 4 h, cells were removed from the culture well via scraping and the cell suspension 
was centrifuged (300g; 10 min; 4°C). Following centrifugation, the supernatants were 
discarded, cells were resuspended in 100µl of RIPA (modified radioimmuno-
precipitation) lysis buffer (1x PBS, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS) 
containing PMSF (Sigma), protease and phosphatase inhibitors (Protease Inhibitor 
Cocktail, Sigma, and Halt Phosphatase Inhibitor Cocktail, Pierce [Rockford, IL], 
respectively), and held on ice for 30 min with occasional pipetting to disrupt cell 
membranes.  Protein concentration in the cell lysates was determined using the Bradford 
method with reagents obtained from Bio-Rad (Hercules, CA) with BSA as a standard.  
Aliquots of each sample were diluted in reducing sample buffer and heat denatured for 5 
min at 95 ºC.  Twenty micrograms of total protein were loaded and separated on a 10% 
SDS-PAGE gel, transferred to a PVDF membrane, and the membranes were blocked in 
5% milk for 1 h at RT.  The membranes were then incubated overnight with rabbit 
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antibodies specific for the non-phosphorylated or phosphorylated p38 (Cell Signaling 
Technology, Beverly, MA) at 1:1000 and 1:500 dilutions, respectively, washed 3x, and 
then probed with goat anti-rabbit secondary antibody conjugated with horseradish 
peroxidase (Bio-Rad) at a 1:10,000 dilution.  The blots were exposed to SuperSignal 
West Pico chemiluminescent substrate (Pierce) for up to 5 min and then enclosed in 
transparent covers prior to exposure to x-ray film.  Band density was analyzed using the 
UN-SCAN-IT software package (Silk Scientific Inc., Orem, UH). 
 
 Phospho-p38 analysis by flow cytometry.  Four ml of 0.5 x 106 cells/ml N9 cell 
suspension (2 x106 cells/well) were plated overnight in 6-well plates as described above. 
Cells were incubated with Mn/LPS for 15 min, 1, and 4 h. Following incubation, cells 
were lifted from the culture wells with a cell lifter, spun down (10 min; 300 xg; 4 ºC), 
and resuspended in 0.5 ml of PBS.  Cells were then fixed by adding of 0.5 ml of 4% 
paraformaldehyde (2% final concentration) to the tubes and incubating them for 10 min 
at 37ºC. Next, the cells were chilled for 1 min on ice, centrifuged (10 min; 300 xg; 4 ºC), 
and permeabilized by resuspending them in 1 ml of 90% methanol and an incubation for 
30 min on ice, followed by an overnight incubation at -20 ºC. The next day, cells were 
centrifuged to remove the methanol and washed twice with a binding buffer (1% BSA in 
PBS, 2 ml for each wash). Next, 1 ml of the cell suspension (approximately 0.6 x 106 
cells) was transferred to flow tubes, spun down, and resuspended in 100 µl of binding 
buffer. Following 10 min incubation at RT, 10 µl/tube of the anti-phospho-p38 
(T180/Y182)-PE pre-titrated antibody, or an appropriate PE-conjugated isotype control 
(mouse IgG1; both from BD Biosciences, San Diego, CA) were added and the tubes 
 25
incubated for 60 min at RT in the dark. At the end of this incubation, the cells were 
washed twice with a binding buffer, resuspended in 0.5 ml of PBS and analyzed by 
FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). 
p38 activity analysis.  The enzymatic activity of the phosphorylated p38 was 
determined by a western blot analysis using the p38 MAP Kinase Assay Kit (Cell 
Signaling Technology).  Briefly, following exposure to Mn and/or LPS the cells were 
rinsed once with ice-cold PBS followed by incubation with 0.5 ml of ice-cold 1x lysis 
buffer containing 1mM PMSF for 5 min.  Cells were scraped and transferred to 1.5 ml 
tubes, sonicated 4x for 5 sec, and centrifuged (14,000 x g) for 10 min at 4 ºC.  Next, 20 µl 
of bead-immobilized antibody slurry was added to 200 µl of sample supernatant and 
incubated overnight at 4 ºC.  After centrifugation (14,000 x g) for 10 min at 4 ºC), the 
samples were washed (2x) in 1x lysis buffer followed by 2 washes in 1x kinase buffer.  
Finally, each sample was resuspended in 50 µl of 1x kinase buffer supplemented with 
200 µM ATP and 2 µg of kinase substrate (ATF-2 fusion protein). All samples were 
incubated for 30 min at 30 ºC.  The kinase reaction was terminated by denaturing at 95 
°C for 5 min in 3x SDS sample buffer containing 150 mM DTT. The samples were 
electrophoretically separated (10% SDS-PAGE gel) and transferred to PVDF membranes.  
The membranes were blocked in 5% w/v nonfat milk and probed with a polyclonal, 
rabbit IgG anti-Phospho-ATF-2 (Thr71) antibody at a 1:2000 dilution.  Following 
washing (3X), the membranes were incubated with HRP-conjugated anti-rabbit IgG and 
HRP-conjugated anti-biotin antibody (for biotinylated protein molecular weight markers).  
The membranes were incubated for 1 min in LumiGLO substrate and wrapped in sheet 
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protectors.  The membranes were exposed to X-ray film for 10 s, the films developed and 
band density analyzed using the UN-SCAN-IT software package. 
 
  Statistical analysis.  Data were analyzed using analysis of variance (ANOVA).  
When statistical differences were detected (P < 0.05), treatment means were separated by 






Pharmacological manipulation. To determine the time-dependency in the ability 
of Mn to enhance LPS-induced pro-inflammatory cytokine production and its association 
with  p38, in addition to exposing cells to Mn+LPS as before (Filipov et al., 2005), we 
exposed cells to 250 µM Mn 3 h before or after activation by 100 ng/ml LPS.  As 
previously observed, exposure to Mn+LPS potentiated the microglial production of TNF-
α (Figure 2.1A) and IL-6 (Figure 2.1B).  Cells activated with LPS 3 h before or after 
exposure to 250 µM Mn produced more TNF-α (Figure 2.1A) and IL-6 (Figure 2.1B) in 
comparison to LPS-alone.  In terms of the timing of exposure to Mn or LPS, the observed 
potentiation effect was the lowest when Mn was added 3 h after LPS, but, nevertheless, 
the potentiation was still present. 
Exposure to 250 µM Mn and 50 µM SB203580 3 h after LPS activation prevented 
Mn-induced potentiation of TNF-α and IL-6 (Figures 2.1A and 2.1B).  Similarly, 
exposure to Mn followed by SB203580 and LPS 3 h later also prevented Mn-induced 
potentiation of TNF-α and IL-6 (Figures 2.1A and 2.1B, respectively).  Additionally, 
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SB203580 inhibited cytokine production in cells exposed simultaneously to Mn+LPS, 
regardless of whether Mn+LPS exposure occurred before, or after, SB203580 (Figures 
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Figure 2.1     Effect of delayed exposure to Mn and/or SB203580 (a p38 inhibitor) on  
 LPS-activated microglial cytokine production. 
 
 TNF-α (1A) and IL-6 (1B) production was analyzed in supernatants  
 collected 24 h after exposure of N9 microglial cells to LPS (100 ng/ml) then  
 Vehicle (3 h later), Mn (250 µM) + LPS then Vehicle (3 h later), LPS then  
 Mn (3 h later), Mn then LPS (3 h later), LPS then SB203580 (3 h later), LPS  
 then Mn + SB203580 (50 µM),  Mn then LPS + SB203580, Mn + LPS then  
 SB203580, and SB203580 then Mn + LPS.  Media levels of TNF-α and IL- 
 6 were analyzed by respective DuoSet ELISA as described in the Materials  
 and Methods. Data shown in each bar represent the mean ± S.E.M. of 4-8  
 independent replicates.  a, b, c, d Presence of  different letters indicate bars are   
 significantly different from control and previous exposures (P < 0.05).  
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Immunoblot analysis of p38 and phospho-p38 protein levels. To examine p38 
activation, we studied the induction of p38 phosphorylation following exposure to Mn 
(250 µM) with and without LPS (100 ng/ml) for up to four hours after exposure.  The 
levels of non-phosphorylated p38 (all exposures) did not change in response to Mn and/or 
LPS exposure (data not shown).  However, induction of p38 phosphorylation (normalized 
to non-phosphorylated p38) was observed as early as 15 min following Mn and/or LPS 
exposure (Figure 2.2A).  Increased phosphorylation was observed at 1 h for Mn+LPS and 
this effect persisted through the 4 h time point (Figures 2.2B and 2.2C, respectively).  On 
the other hand, the LPS-induced phosphorylation had almost returned to control levels, 
































































































































Figure 2.2 Densitometric analysis (left panels) and representative western blots (right  
 panels) of phosphorylated p38 kinase in N9 microglia exposed to Mn, LPS,  
 or Mn+LPS.   
 
 (A) Phosphorylated p38 protein from N9 cells exposed to vehicle, 250 µM  
 Mn, 100 ng/ml LPS, or 250 µM Mn+100 ng/ml LPS for 15 min (A), 1 h (B)  
 and 4 h (C). Western blots and densitometric analyses were performed as  
 described in the Materials and Methods. Data shown in each bar represent  
 the mean ± S.E.M. of the adjusted pixel density for phosphorylated p38  
 normalized to non-phosphorylated p38.  Each bar represents a minimum of  
 3 independent replicates. a Presence of letters indicate treatment differences  
 within a time point (P < 0.05). 
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Phospho-p38 analysis by Flow Cytometry. Similar to the western blot data 
(Figure 2.2), flow cytometry results indicated a time-dependent effect of LPS, Mn, and 
Mn+LPS on phospho-p38 (Figure 2.3). Thus, in the absence of Mn, 100 ng/ml LPS-
induced increase was rapid (15 min), but it plateaued at 1 h and begun to subside at the 4 
h time point.  On the other hand, 250 µM Mn increased the phospho-p38 levels by 15 min 
in comparison with the effect being significant at the 1 and 4 h time points.  While at 15 
min the Mn+LPS combination increased phospho-p38 to an extent similar to LPS, at the 
1 and 4 h time points, the Mn+LPS effects were greater than the effects of either Mn or 
LPS alone.  Importantly, similar to the western blot data, by 4 h the LPS-induced 





































































































Figure 2.3 Phosphorylated p38 protein levels in N9 microglia exposed to 250 µM with  
 or without 100 ng/ml LPS.   
 
 Cells collected after 15 min, 1 h, or 4 h exposure were analyzed by flow  
 cytometry as described in the Materials and Methods.  Data shown represent  
 the mean fluorescence intensity (MFI) change from the 15 min control ±  
 S.E.M. for two independent experiments where each experimental condition  
 was independently replicated (n =4). a, b Presence and different letters  
 indicate treatment differences within a time point (P < 0.05). 
 
p38 activity.  The kinase activity of p38 was measured using western blot detection of a 
phosphorylated-substrate (ATF-2 Fusion Protein).  Exposure to 250 µM Mn, 100 ng/ml 
LPS, or Mn+LPS increased p38-kinase activity at 15 min and 4 h compared to control 
(Figures 2.4A, and 2.4B).  This effect persisted through the 4 h time point, but only for 
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Figure 2.4     p38 activity following exposure to vehicle, 250 µM Mn and/or 100 ng/ml  
 LPS for 15 min (A), 1 h (B), or 4 h (C) in N9 microglia cells.   
 
 The p38 activity in whole cell lysates was analyzed by western blot for the  
 detection of a phosphorylated p38 substrate (ATF-2 Fusion Protein)  
 followed by densitometric analyses (left hand panel) as described in the  
 Materials and Methods.  Blots representative of three independent  
 experiments are shown in the right hand panel. Data shown in each bar  
 the mean ± S.E.M. of the total pixel density for 3 independent replicates. a,b  
 Presence and different letters indicate treatment differences within a time  




Although it has been demonstrated that microglia play a role in basal ganglia 
neurotoxicity (Olanow and Tatton, 1999; Castano et al., 2002), how environmental 
toxicants like Mn contribute to microglial-mediated inflammation has only recently been 
explored. Brain regions that possess an abundance of microglial cells are especially 
sensitive to inflammatory stimuli, particularly the bacterial endotoxin LPS (Kim and de 
Vellis, 2005).  Activation of macrophages and microglia by LPS is thought to occur 
(primarily) by binding of LPS to TLR4, leading to activation of intracellular kinases (i.e. 
MAPK) and transcription factors like NF-κB (Medzhitov and Janeway, 1997; Takeda and 
Akira, 2004).  Moreover, activation of the MAPK and NF-κB by LPS results in the 
production of inflammatory mediators such as NO and TNF-α (Bhat et al., 1998; Lee et 
al., 1993; Lee et al., 1994).  
Previous research has demonstrated that Mn exposure, in combination with LPS, 
can increase the production of iNOS and NO by microglial cells (Chang and Liu, 1999; 
Filipov et al., 2005; Chen et al., 2006),  as well as the production of the inflammatory 
cytokines TNF-α (Filipov et al., 2005; Chen et al., 2006) and IL-6 (Filipov et al., 2005).  
On its own, Mn exposure increases the cytokine production only slightly and at higher 
concentrations, suggesting that microglial activation must be present in order for the Mn 
effects on TNF-α and IL-6 to be observed. In this study, similar to Filipov et al., (2005), 
we observed a strong potentiation of TNF-α and IL-6 production by N9 microglial cells 
following exposure to Mn+LPS compared to exposure to LPS alone.  Interestingly, Mn-
potentiation of IL-6 in activated microglia was greater than for TNF-α, with IL-6 
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concentrations increasing 5-fold or more, in comparison to 2-fold changes in TNF-α.  On 
the other hand, exposure to the p38 inhibitor SB203580 inhibited TNF-α in Mn+LPS-
exposed cells to a greater extent than the inhibition observed for IL-6, suggesting that 
although both cytokines depend on p38 for their synthesis, the degree of dependency may 
be different for the two cytokines 
Importantly, we were also able to demonstrate that Mn can potentiate LPS-
induced cytokine production if the Mn-exposure occurs 3 h after the exposure to the 
inflammatory stimulus, or, alternatively, that prior (3 h) exposure to Mn can potentiate 
the LPS-induced inflammatory cytokine production.  To our knowledge, this is the first 
report of this observation, providing additional data to support the hypothesis that Mn 
exposure can potentiate the production of inflammatory cytokines in vitro and, possibly, 
inflammation in vivo not only in cases of co-exposure to an inflammogen and Mn, but 
also in cases where the exposure is, within a (possibly) narrow window, sequential.   
LPS has been shown to activate the MAPK family of kinases, leading to the 
production of inflammatory mediators such as NO and TNF-α (Bhat et al., 1998; Lee et 
al., 1993; Lee et al., 1994).  While for microglia, both p38 and ERK MAPK have been 
shown to contribute to the production of inflammatory mediators (Bhat et al., 1998; 
Jeohn et al., 2002a; Koistinaho and Koistinaho, 2002; Zarubin and Han, 2005), p38 
appears to play a dominant role.  For example, LPS-stimulated production of NO and 
cytokines by microglia can be inhibited by prior exposure to a p38 inhibitor (Bhat et al., 
1998; Jeohn et al., 2002a).  This is also the case with Mn potentiation of LPS-induced 
cytokine expression in the present study, as exposure to SB203580 before or after 
exposure to Mn+LPS inhibited the production of IL-6 and TNF-α by N9 microglial cells.  
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In support, our western blot and flow cytometry p38 activity data indicated that the 
increased p38 activity caused by Mn persists for at least 4 h.    
In contrast, the ERK inhibitor (PD98059) has a very small effect on  IL-6 and 
TNF-α production by the Mn+LPS exposed microglia (Crittenden, 2004; data not 
shown), suggesting that activation of other MAPK which are known to contribute to the 
production of inflammatory mediators in microglia (Bhat et al., 1998; Koistinaho and 
Koistinaho, 2002; Zarubin and Han, 2005), play only a minor role in the Mn+LPS-
induced production of TNF-α and IL-6.  
Two other recent studies have investigated the role of intracellular kinases in the 
Mn effects on NO/iNOS and/or TNF-α production using the microglial cell line BV-2 
(Bae et al., 2006) or primary mixed glial cells (Chen et al., 2006). Bae et al. (2006) 
examined the effects of Mn (100 µM to 1 mM) by itself only on iNOS and suggested that 
multiple MAP kinases were phosphorylated by Mn and that, based on inhibitor data, the 
p38 kinase appeared not to play a major role in the Mn-induced iNOS. Nevertheless, even 
though not quantified, these authors did report that p38 phosphorylation was increased by 
Mn at 1, 3 and 6 h post exposure, thus agreeing with our data.  In their studies with 
primary glial cells, which contain both astrocytes and microglia (85 and 15% , 
respectively), Chen et al. (2006) observed that (i) the phosphorylation of multiple (p38, 
ERK, JNK) kinases was induced by 30 min exposure to Mn, either by itself or in 
combination with LPS/IFN-γ, (ii)  similar to our present data and to Filipov et al. (2005), 
while having no effect on its own, Mn potentiated TNF-α production by glial cells 
exposed to LPS/IFN-γ, and (iii) pharmacological inhibition of p38 was one of the ways of 
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inhibiting the potentiating effect of Mn on TNF-α production. Interestingly, these authors 
also suggested that iNOS/NO production may be regulated in a manner different from 
that of TNF-α. Importantly, similar to our present studies, Chen et al. (2006) indicated 
that an activation of MAPKs by Mn is not sufficient to trigger the glial cell production of 
TNF-α, but that it is critical for the potentiating effects of Mn on LPS/IFN-γ -stimulated 
TNF-α production to be observed.  
Having observed that p38 was required for the Mn-potentiation of cytokine 
production, it was necessary to examine p38 phosphorylation directly as enhanced 
phosphorylation is associated with increased activity and thus could increase the 
production of IL-6 and TNF-α. Indeed, this observation was supported by western blot 
analysis and flow cytometry.  Although LPS did increase the phosphorylation of p38 
through the 1 h time point, by 4 h this effect had diminished.  In contrast, prolonged 
phosphorylation of p38 was observed in Mn-exposed cells, persisting through the 4 h 
time point.    In comparison, increased p38 activation was observed in Mn-exposed cells, 
an effect that persisted through the 4 h time point.  LPS alone increased p38 activity, 
however by 4 h the LPS-induced increase in p38 activity had largely subsided.  
Moreover, we have observed enhanced p38 activation 24 h following exposure to Mn or 
Mn+LPS (data not shown).    
While p38 is clearly associated with the Mn-potentiation of TNF-α and IL-6 by 
activated microglia, how Mn enhances the phosphorylation and activity of p38 is not 
apparent at this time.  One possibility is that Mn acts at a site other than p38, perhaps 
upstream at the level of the MAPK kinase (MKK).  The MKKs are responsible for 
phosphorylating MAPK to its active form.  Two MKK that are known to activate p38 are 
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MKK3 and MKK6 (Koistinaho and Koistinaho, 2002; Zarubin and Han, 2005).  
Increased activity by MKK3 or MKK6 could lead to enhanced p38 MAPK activation 
(Enslen et al., 1998).  Alternatively, inhibition of the enzymes responsible for 
inactivating p38, the dual specificity phosphatases (DUSP; Groom et al., 1996), may be 
responsible for the prolonged phosphorylation following exposure to Mn/LPS that was 
observed in the current study.  In this regard, another metal, arsenic, has been shown to 
inhibit a different DUSP responsible for maintaining low basal levels of JNK (Cavigelli 
et al., 1996).  Additionally, it has been demonstrated that ERK can negatively regulate 
p38 via the MAPK phosphatase MKP-1 (Carter et al., 1999).  It is possible that Mn 
inhibits either ERK-mediated activation of MKP-1 or, MKP-1 activity. 
Our earlier study indicated that the Mn-induced potentiation of IL-6 and TNF-α is 
NF-κB dependent (Filipov et al., 2005).  With our present study we demonstrate that p38 
is critical for the Mn-induced potentiation of cytokine production to occur.  Exactly how 
NF-κB and p38 are interacting in Mn+LPS exposed microglia is the subject of future 
studies.  A possible mechanism involves NF-κB and regulation of gene transcription. 
Active p38 phosphorylates the TATA-binding protein (TBP), resulting in the association 
of TBP with the TATA-promoter as it has already been demonstrated that p38 
phosphorylation of TBP is required for NF-κB-dependent gene expression, including 
TNF-α and IL-6 (Carter et al., 1999).  As Mn-potentiation of LPS-induced inflammatory 
cytokine production appears to require both p38 and NF-κB, it is possible that the 
observed increases in p38 activity may increase phosphorylation of TBP leading to 
enhanced NF-κB-dependent gene expression of IL-6, TNF-α and, possibly, other 
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inflammatory mediators.  This is further supported by the observation in the present study 
that increased phosphorylation of p38 was observed in cells exposed to Mn in the absence 
of LPS. However, Mn exposure alone resulted in negligible amounts of IL-6 and TNF-α 
produced by the N9 microglia as demonstrated in our previous study (Filipov et al., 
2005). As synthesis of IL-6 and TNF-α is NF-κB-dependent, and exposure to LPS leads 
to activation of NF-κB, it is likely that Mn-potentiation of inflammatory cytokine 
production occurs via a p38-dependent mechanism, but requires the 
subsequent/concurrent activation of NF-κB. Considering the interactive nature of 
intracellular signaling, it is possible that Mn may be acting at multiple sites leading to 
increased p38 phosphorylation and activity and subsequent IL-6 and TNF-α production 























































Figure 2.5 Diagram of potential/known Mn sites of action in microglial intracellular  
 signaling following activation with LPS.   
 
 Small arrows indicate known intracellular signaling pathways while larger  
 arrows indicate possible sites of interaction between signaling molecules  
 and Mn.  Large arrows with a ‘?’ denote potential sites of action for Mn- 
 enhanced p38 activity.  Abbreviations:  LPS (Lipopolysaccharide), LBP  
 (LPS Binding Protein), TLR4 (Toll Like Receptor 4), MKK3/6 (Mitogen  
 Activated Protein Kinase Kinase) p38 (p38 Mitogen Activated Protein  
 Kinase), p38-p (phosphorylated p38), ERK (Extracellular Signal-Regulated  
 Kinase), MKP-1 (Mitogen-activated protein kinase phosphatase-1), IkB  
 (Inhibitor of NF-kB), NF-kB (Nuclear Factor kappa B), TBP (TATA- 
 Binding Protein), TATA (TATA Box).   
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In summary, enhanced production of inflammatory cytokines by microglia 
exposed to Mn/LPS is associated with persistent activation of p38 and inhibition of p38 
prevents this enhancement. Importantly, the increase cytokine production by Mn+LPS 
occurs regardless whether the exposure to Mn and LPS is concurrent or sequential (3 h 
apart); in all cases, the potentiation is prevented by inhibition of p38. Overall, our data 
suggest that exposure to environmental toxicants, such as Mn, may prolong microglial 
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 In previous work we have demonstrated that manganese (Mn) exposure 
potentiates inflammogen (lipopolysaccharide; LPS)-induced inflammatory cytokine (e.g. 
IL-6 and TNF-α) production by microglial cells and that this potentiation is associated 
with enhanced and sustained p38 mitogen activated protein kinase (p38) activity.  To 
explain the enhanced p38 activity, we hypothesized that Mn either augmented the activity 
of the kinases upstream of p38 (i.e. MKK-3/6, MKK-1/2, and/or MKK-4) or decreased 
activity of the major phosphatase responsible for p38 inactivation, MKP-1 (mitogen 
activated protein kinase phosphatase-1).  We examined MKK activity following 1 or 4 h 
exposure to Mn (250 µM), LPS (100 ng/ml), or Mn+LPS and observed that Mn in 
combination with LPS increased phosphorylation of all three MKKs at 1 h, and MKK-3/6 
at 4 h.  However, for MKK-3/6, the observed activation by Mn+LPS was not different 
from the phosphorylation caused by LPS alone; indicating that the enhanced p38 activity 
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in the presence of Mn was not due to increased MKK-3/6 activation.  In contrast to the 
lack of effect of Mn on MKK-3/6, Mn+LPS exposure increased the phosphorylation of 
MKK-1/2 and -4 at 1 h more than exposure to LPS alone, suggesting that effects of 
Mn+LPS on MKK-1/2 and -4 may lead to the previously observed enhanced p38 activity.  
Next, we examined the negative regulator of p38, MKP-1, by western blot and 
quantitative PCR.  Exposure to Mn alone or in combination with LPS (1 h) decreased 
both mRNA levels and the protein expression of MKP-1 relative to the MKP-1 levels in 
control and LPS-exposed cells, respectively. Additionally, to correlate the sustained 
increase of p38 by Mn+LPS with the increased inflammatory mediator production (i.e. 
cytokines and prostaglandins), we performed a time-course mRNA study.  Compared to 
the effects of LPS alone, further increase in TNF-α mRNA expression by Mn+LPS was 
observed as early as 1 h, while Mn+LPS markedly increased TNF-α, IL-6, and Cox-2 
mRNA at 4 h, a time point coinciding with increased p38 activity.  Thus, it appears that 
the enhanced and sustained p38 activity and, at least in part, inflammatory mediator 
expression by activated microglia exposed to Mn, may be due to decreased MKP-1 as 
well as enhanced MKK-1/2 and -4 activities.  
 
Introduction 
Manganese (Mn) is an essential metal and a common environmental contaminant.  
Besides mining operations, Mn is found in alloys, fertilizers, batteries, certain fungicides, 
and as a component of the fuel additive methylcyclopentdienyl manganese tricarbonyl 
(MMT; Frumkin and Solomon, 1997; Aschner, 2000).  Excessive exposure to Mn is of 
human health concern, since occupational exposure to Mn is linked to a specific 
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neuropathology, manganism, that is characterized by clinical signs and lesions similar to 
Parkinson’s Disease (PD; Calne et al., 1994; Meco et al., 1994; Frumkin and Solomon, 
1997; Aschner, 2000; Huang et al., 2007). Although Mn is thought to exert its effects, at 
least partially, by disrupting neuronal mitochondrial respiration, leading to increased 
oxidative stress and cell death (Gavin et al., 1999), it has also been shown that Mn can 
potentiate the production of inflammatory mediators by non-neuronal cells resident in the 
CNS (Spranger et al., 1998; Chang and Liu, 1999; Barhoumi et al., 2004; Filipov et al., 
2005; Chen et al., 2006; Crittenden and Filipov, 2008).  
Inflammatory responses are essential for the maintenance and defense of tissues. 
However, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis, 
especially in sensitive tissues such as the nervous system (Perry et al., 1998). In fact, 
abnormally high levels of inflammatory cytokines, e.g. TNF-α, have been implicated in 
the etiology of PD (Nagatsu et al., 2000).  For example, astrocytes accumulate Mn and 
may produce reactive oxygen species (ROS) and other substances that may be damaging 
to neurons (Aschner, 2000).  Importantly, it has been demonstrated that microglia, the 
resident brain macrophage, and/or astrocytes may produce inflammatory mediators that 
could be involved in the mechanisms of Mn neurotoxicity, especially in cases where an 
additional inflammatory stimulus such as lipopolysaccharide (LPS) is present (Spranger 
et al., 1998; Chang and Liu, 1999; Filipov et al., 2005; Crittenden and Filipov, 2008).  
LPS is a known environmental contaminant (Niehaus and Lange, 2003) and model 
inflammogen due to its ability to stimulate inflammatory cells (microglia/macrophages) 
to produce cytokines, nitric oxide (NO), and ROS (Chao et al., 1992; Jeohn et al., 2002b; 
Liu et al., 2002).   
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Binding of LPS to CD14 and TLR4 cell surface receptors leads to the activation 
of intracellular kinases, including the mitogen activated protein kinases (MAPK; Bhat et 
al., 1998; Jeohn et al., 2002b).  The MAPK family of proteins is comprised of a series of 
kinases, beginning with the MAP kinase kinase kinases (i.e. TAK1) that phosphorylate 
MAP kinase kinase (i.e. MKK-1, -2, -3, -4, -6), which subsequently phosphorylate 
MAPK.  This MAPK cascade culminates in the activation of one or more MAPK, 
including the extracellular signal-regulated kinases (ERK), stress-activated or c-Jun N-
terminal kinases (SAPK/JNK), and the p38 MAPK (Koistinaho and Koistinaho, 2002). 
Of these MAPKs, p38 MAPK (p38) and ERK appear to be primarily involved in the 
production of inflammatory mediators by microglia (Koistinaho and Koistinaho, 2002).  
MAPK deactivation is dependent on the actions of dual specificity phosphatases (DUSP), 
primarily MAP kinase phosphatase-1 (MKP-1; Koistinaho and Koistinaho, 2002; Lang et 
al., 2006; Wang and Liu, 2007).  
In primary microglia and microglial cell lines, LPS has been shown to increase 
the phosphorylation of ERK and p38, as well as increase the expression of iNOS and 
TNF-α in a time- and dose-dependent manner (Lee et al., 1993; Lee et al., 1994; Bhat et 
al., 1998). Of note, LPS-induced, p38-dependent, increases in NO and TNF-α by 
microglia have been shown to decrease neuronal survivability in neuronal-glial co-culture 
(Jeohn et al., 2002a). The fact that this effect can be inhibited by pretreatment with 
inhibitors of p38 suggests that p38 plays a dominant role in the process (Bhat et al., 1998; 
Jeohn et al., 2002b).  
Within the context of Mn neurotoxicity, Mn enhances the production of 
inflammatory mediators by microglia.  Indeed, exposure to Mn potentiates LPS-induced 
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production of inflammatory cytokines (TNF-α & IL-6) and NO in vitro (Filipov et al., 
2005; Crittenden and Filipov, 2008).  In addition, Mn also potentiates Cox-2 expression 
and ensuing prostaglandin production by inflammogen-activated mixed glial cells (Liao 
et al., 2007). Potentiating effect of Mn on TNF-α and IL-6 involves the activation of NF-
kB and p38, as inhibitors of NF-kB and p38 were able to prevent the potentiation 
observed in Mn+LPS exposed cells (Filipov et al., 2005; Crittenden and Filipov, 2008).  
Furthermore, the p38-mediated effect is independent of the timing of exposure to Mn, as 
Mn exposure 3 h before or after LPS, potentiated inflammatory cytokine production 
(Crittenden and Filipov, 2008).  Whether the potentiating effects of Mn on cytokine 
production (and other inflammatory molecules) is at the level of transcription, and the 
temporal relationship with p38, is unknown is present.   
Additionally, p38-phosphorylation alone did not explain the enhanced production 
of TNF-α and IL-6 in the presence of Mn+LPS, as LPS by itself increased the 
phosphorylation of p38 at earlier time points (up to 1 h) to levels comparable to the 
effects of Mn+LPS (Crittenden and Filipov, 2008).  However, Mn+LPS exposure not 
only increased p38 activity, but also prolonged it up to 4 h following the initial exposure, 
a time point at which the LPS-increased p38 activity had subsided (Crittenden and 
Filipov, 2008).   
The mechanism of prolonged p38 activation in the presence of Mn is not 
understood.  It may be that Mn enhances, or prolongs, the activation of the MKKs 
responsible for the activation of p38, primarily MKK-3/6 (Enslen et al., 1998). However, 
MKK-1/2 (Meja et al., 2000) and MKK-4 (Derijard et al., 1995) may also activate p38.  
Alternatively, decreased expression of MKP-1, the DUSP responsible for 
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dephosphorylating p38, may lead to prolonged p38 activation (Hammer et al., 2005; 
Lang et al., 2006; Wang and Liu, 2007).  
To test these hypotheses, the major objectives of this study were to examine the 
effects of Mn+LPS exposure on the MKKs responsible for activating p38 (e.g. MKK-3/6, 
MKK-1/2, MKK-4) and on the major phosphatase responsible for deactivating p38, 
MKP-1.  We have previously reported that Mn potentiates TNF-α and IL-6 production by 
LPS-activated microglia at the protein level (Filipov et al., 2005), and that this 
potentiation is prevented by inhibition of p38 (Crittenden and Filipov, 2008).  However, 
nor we or others have determined whether the potentiative effect of Mn on cytokine 
production occurs at the level of transcription.  Therefore, an additional goal was to study 
the time-course of the expression of certain inflammatory mediators (e.g. TNF-α, IL-6, 
and Cox-2) in Mn+LPS-exposed microglia at the mRNA level, thus allowing us to 
determine whether the potentiating effect of Mn is at the transcription level and whether 
enhanced mRNA for TNF-α, IL-6, and Cox-2 by Mn+LPS coincides temporally with the 
previously observed increased p38 activity.  
 
Materials and Methods 
 
 
 Chemicals.  Unless specified, all chemicals and reagents were purchased from  
 
Sigma-Aldrich (Sigma; St. Louis, MO) and MnCl2 with purity >99% was used. 
 
 
Cell Culture.  The N9 mouse microglial cell line (Righi et al., 1989) was a gift 
 
kindly provided by Dr. P. Ricciardi-Castagnoli (University of Milan, Italy) and is similar  
 
to primary microglia and other cell lines, i.e. N13, in that it produces inflammatory  
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cytokines, such as IL-1β, IL-6, and TNF-α, as well as NO when activated by  
 
inflammogens such as LPS (Righi et al., 1989; Heyen et al., 2000).  The cultures were  
 
maintained (5% CO2, 95% air, at 37°C) in RPMI-1640 supplemented with 10% Hyclone  
 
FBS (low endotoxin, ≤ 25 EU/ml; Hyclone, Logan, UT), 0.075% sodium bicarbonate, 1  
 
mM sodium pyruvate, 1 mM non-essential amino acids, 2 mM L-glutamine, 50 µM 2- 
 
mercaptoethanol, 25 µg/ml gentamycin, 100 U/ml penicillin G, and 100 mg/ml  
 
streptomycin (all from Invitrogen, Carlsbad, CA).  For real-time quantitative PCR  
 
(qPCR) and western blot protein analysis, cells were seeded at 2.5 x 106 cells/well (5 ml  
 
volume) in 6-well plates (Costar) and allowed to adhere overnight prior to exposure to  
 
Mn or LPS.  Cells were incubated for up to 4 h in the presence of Mn (250 µM) and/or  
 
LPS (Escherichia coli 0111: B4; 100 ng/ml).  
 
In previous studies (Filipov et al., 2005), Mn concentrations of 50-500 µM and  
 
LPS amounts of 10-1000 ng/ml were used, and the potentiation of cytokine production  
 
was both Mn- and LPS-dependent.  Similar concentrations of Mn and LPS were used in  
 
this study based on previous experiments that indicated no significant N9 cell death  
 
following exposure to Mn and/or LPS at these concentrations (Filipov et al., 2005).   
 
These observations are in line with numerous other in vitro studies where levels of Mn  
 
(Mn2+) range from 10 µM to 4 mM with the most typical exposure range being 100 to  
 
500 µM (Malthankar et al., 2004; Li et al., 2005). Moreover, the above concentrations  
 
and the concentrations used in our study are representative of Mn levels found in brains  
 
of non-human primates following exposure to manganese dioxide for 3 months (ranging  
 
from 35 to 350 µM; Suzuki et al., 1975) and are in line with basal ganglia Mn levels  
 
observed in the brains of PD patients (Yase, 1972), as well as in autopsied brains of  
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patients with cirrhosis (Yase, 1972). Of note, the concentration of LPS we have used in  
 
the present study (100 ng/ml) is relatively low and we have already reported that when  
 
greater amounts of LPS are present in the culture medium, less Mn is required for a  
 
potentiating effect on cytokine production to be observed (Filipov et al., 2005).  
 
Dexamethasone (Dex) was used as a positive control for MKP-1, based on  
 
published data showing induction of MKP-1 in the presence of Dex, as well as the  
 
enhancement of LPS-induced expression of MKP-1 following exposure to both Dex+LPS  
 
(Zhou et al., 2007). 
 
 
Immunoblot analysis of MKK and MKP-1.  After incubation for 1 and 4 h, 
 
 cells were removed from the culture wells via scraping and the cell suspensions were  
 
centrifuged (300g; 10 min; 4°C). Following centrifugation, the supernatants were  
 
discarded, cells were resuspended in 100µl of RIPA (modified radioimmuno- 
 
precipitation) lysis buffer (1x PBS, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS)  
 
containing PMSF (Sigma), protease and phosphatase inhibitors (Protease Inhibitor  
 
Cocktail, Sigma, and Halt Phosphatase Inhibitor Cocktail, Pierce [Rockford, IL],  
 
respectively), and held on ice for 30 min with occasional pipetting to disrupt cell  
 
membranes.  Protein concentration in the cell lysates was determined using the Bradford  
 
method with reagents obtained from Bio-Rad (Hercules, CA) and with bovine serum  
 
albumin (BSA) as a standard.  Aliquots of each sample were diluted in reducing sample  
 
buffer and heat denatured for 5 min at 95 ºC.  For gel electrophoresis, Kaleidoscope  
 
Molecular Weight Standard (Bio-Rad; Hercules, CA) was included as a western blot  
 
transfer control, while Magic Mark (Invitrogen; Carlsbad, CA) was used for molecular  
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weight determination and transfer control on the x-ray film.  Twenty micrograms of total  
 
protein (MKK-3/6), 30 µg for MKK-1/2 and MKK-4, or 50  µg (MKP-1), was loaded and  
 
separated on a 10% SDS-PAGE gel, transferred to a PVDF membrane, and the  
 
membranes were blocked in 5% milk (MKK-3/6 and MKP-1) or fish gelatin (MKK-1/2  
and MKK-4) for 1 h at RT.  The membranes were then incubated overnight at 4ºC with  
antibodies specific for the non-phosphorylated (1:1000) and phosphorylated (1:500)  
 
MKK-3/6 (Cell Signaling Technology, Beverly, MA), phosphorylated (1:1000) MKK-1/2  
 
and MKK-4 (Santa Cruz Biotechnology Inc, Santa Cruz, CA) and  (1:500) MKP-1  
 
protein (Santa Cruz). Following a wash (3x), the membranes were probed with either  
 
goat anti-rabbit secondary antibody conjugated with horseradish peroxidase (1:10,000,  
 
Bio-Rad) for MKK-3/6 and MKP-1, or rabbit anti-goat secondary antibody conjugated  
 
with horseradish peroxidase (1:30,000, Santa Cruz) for MKK-1/2 and MKK-4.  Next, the  
 
blots were exposed to SuperSignal West Pico chemiluminescent substrate (Pierce) for up  
 
to 5 min and then enclosed in transparent covers prior to exposure to x-ray film.  Band  
 
density was analyzed using the UN-SCAN-IT software package (Silk Scientific Inc.,  
 
Orem, UH).  
 
 
qPCR analysis of MKP-1, IL-6, TNF-α, and Cox-2.  Total RNA was isolated, 
 
 including the recommended DNase treatment step, using the RNeasy Mini Kit (Qiagen,  
 
Valencia, CA) and quantified using the NanoDrop Spectrophotometer ND-1000  
 
(NanoDrop Technologies, Inc.).  One µg of total RNA was used to synthesize the first  
 
strand cDNA. First strand cDNA was synthesized with the RT2 PCR Array First Strand  
 
Kit (SuperArray Bioscience Corporation, Frederick, MD). Using 10 ng starting RNA per  
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sample, expression of pro-inflammatory cytokines (TNF-α and IL-6), Cox-2, and MKP-1  
 
were determined by qPCR (iCycler iQ, Bio-Rad) using mouse-specific, certified primers  
 
(SuperArray, Frederick, MD).  Reaction mixtures were assembled in optical 96 well  
 
plates using the RT-PCR SYBR Green Master Mix (SuperArray). Amplifications were  
 
performed in an iCycler iQ (Bio-Rad) programmed for an initial step of 30 min at 50 °C  
and 10 min at 95 °C, followed by 40 cycles at 95 °C for 15 s and 1 min at 60 °C.  To  
check the quality of the products, the melting curve program was run after the above  
 
cycling program. The expression of GAPDH, which was verified of not being affected by  
 
vehicle/Mn/LPS treatment, was used as a house-keeping gene for all samples.  Data are  
 
presented as relative induction (fold changes) of MKP-1, inflammatory cytokine, or Cox- 
 
2 normalized to GAPDH.  Data shown represent samples from four independent  
 
experiments, and measurements were performed in duplicate. 
 
 
Statistical Analysis.  Data were analyzed using appropriate analysis of variance  
 
(ANOVA).  When statistical differences were detected (P < 0.05), treatment means were  
 





Immunoblot analysis of MKK and MKP-1.  To determine the source of the 
enhanced/prolonged p38 activation observed in the presence of Mn (Crittenden and 
Filipov, 2008), we examined the induction of the MKK upstream of p38 (i.e. MKK-1/2, -
3/6, -4), as well as its main negative regulator, the phosphatase MKP-1.  Following 
exposure to Mn (250 µM), with and without LPS (100 ng/ml) for up to 4 h, levels of non-
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phosphorylated MKK-3/6 (all exposures) did not change in response to Mn and/or LPS 
exposure.  However, induction of MKK-3/6 phosphorylation was observed at 1 h post 
exposure to Mn+LPS or LPS alone; this effect persisted through the 4 h time point 
(Figures 3.1A and 3.1B, respectively).  On the other hand, Mn by itself did not increase 
the phosphorylation of MKK-3/6 at any time and the effect of Mn+LPS was not greater 














































































Figure 3.1    Quantification and western blots shown representative of MKK-3/6  
 phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,  
 or 250 µM  Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.   
 
 Densitometric data were adjusted relative to vehicle control and normalized  
 as a ratio of phosphorylated to total (non-phosphorylated) MKK-3/6 protein.   
 All data points represent means ± SEM from at least 3 independent  
 experiments.  Data were analyzed with ANOVA and means were separated  
 using Fisher’s LSD multiple comparison post hoc test.  Letters denote  
 statistically significant difference at p ≤ 0.05.    
 54
Similar to MKK-3/6, Mn alone did not cause appreciable phosphorylation of 
MKK-1/2 or MKK-4 at 1 or 4 h (Figures 3.2A, 3.2B, 3.3A, and 3.3B, respectively).  
However, at 1 h, the combination of Mn+LPS significantly increased the phosphorylation 
of both MKK-1/2 and MKK-4 to levels greater than the effect of LPS alone (Figures 
3.2A and 3.3A).  This effect was transient, as no statistical differences were observed in 
















































































Figure 3.2   Quantification and western blots shown representative of MKK-1/2  
 phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,  
 or 250 µM  Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.   
 
 Densitometric data for phosphorylated MKK-1/2 are represented as total  
 pixel density.  All data points represent means ± SEM from at least 3  
 independent experiments.  Data were analyzed with ANOVA and means  
 were separated using Fisher’s LSD multiple comparison post hoc test.   















































Figure 3.3    Quantification and western blots shown representative of MKK-4  
 phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,  
 or 250 µM  Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.   
 
 Densitometric data for phosphorylated MKK-4 are represented as total pixel  
 density. All data points represent means ± SEM from at least 3 independent  
 experiments.  Data were analyzed with ANOVA and means were separated  
 using Fisher’s LSD multiple comparison post hoc test.  Letters denote  




 Based on published observations in primary microglia (Zhou et al., 2007), Dex 
with and without LPS was used as a positive MKP-1 control.  Similar to primary 
microglia, Dex+LPS, but not Dex alone, was able to increase the MKP-1 protein levels at 
both 1 and 4 h in N9 microglia (Figures 3.4A and 3.4B).  Dexamethasone alone 
decreased MKP-1 protein levels at 1 h, an effect that was not observed at 4 h (Figures 
3.4A and 3.4B, respectively). In LPS- and Mn+LPS-treated cells, MKP-1 protein levels 
were also increased at 1 h (Figure 3.4A).  However, MKP-1 protein levels in cells 
exposed to Mn were decreased relative to controls at the 1 h time point (Figure 3.4A).  A 
similar decrease in MKP-1 levels was observed in Mn+LPS exposed cells relative to LPS 
alone (Figure 3.4A).  Interestingly, the magnitude of the decrease was similar in both Mn 
and Mn+LPS exposed cells, relative to their respective controls (i.e. vehicle and LPS).  
At 4 h, a rebound effect was observed, as MKP-1 protein expression had significantly 

























































































Figure 3.4    Quantification and western blots shown representative of MKP-1  
 following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS, 250 µM Mn +  
 100 ng/ml LPS, Dex 1 µM, or Dex 1 µM + 100 ng/ml LPS for 1 h (A) and 4  
 h (B).   
 
 Densitometric data for MKP-1 are represented as total pixel density.   
 All data points represent means ± SEM from at least 3 independent  
 experiments.  Data were analyzed with ANOVA and means were separated  
 using Fisher’s LSD multiple comparison post hoc test.  Letters denote  
 statistically significant difference from control and bars with different  
 letters are statistically different from each other at p ≤ 0.05.     
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 qPCR analysis of MKP-1.  Similar to the MKP-1 protein levels, decreased 
expression of MKP-1 mRNA was observed for Mn-exposed cells at 1 h relative to the 
vehicle control (Figure 5A).  Although Mn+LPS increased the overall expression of 
MKP-1 mRNA relative to the vehicle or Mn alone, the effect was less than that of LPS 
alone (Figure 3.5A).  Interestingly, the magnitude of the change in MKP-1 mRNA 
expression in cells exposed to Mn-alone or in combination with LPS, relative to their 
respective controls (vehicle and LPS), was similar (almost 2-fold decrease; Figure 3.5). 
Exposure to Dex or LPS increased MKP-1 mRNA expression (2- and 5-fold, 
respectively).  As expected, the largest increase in MKP-1 mRNA expression was 
observed in the presence of Dex+LPS, the positive control (7.5-fold; Figure 3.5A). 
 In contrast to the 1 h data, and in agreement with the western blot data, Mn 
increased the expression of MKP-1 mRNA at 4 h (Figure 3.5B).  Although the amounts 
of MKP-1 mRNA in Dex, LPS, Mn+LPS, and Dex+LPS  at 4 h were diminished in 
comparison to 1 h exposures,  MKP-1 mRNA in Mn+LPS exposed cells was significantly 






























































































Figure 3.5    Fold change (up/down from vehicle control) in MKP-1 mRNA expression  
 following exposure to 250 µM Mn, 100 ng/ml LPS, 250 µM Mn + 100 ng/ml  
 LPS, Dex 1 µM, or Dex 1 µM + 100 ng/ml LPS for 1 (A) and 4 (B) h.  
 
 All data points represent means ± SEM from 4 independent experiments.   
 Data were analyzed with ANOVA and means were separated using Fisher’s  
 LSD multiple comparison post hoc test.  Letters denote statistically  
 significant difference from control and bars with different letters are  




qPCR analysis of TNF-α, IL-6, and Cox-2.  To examine the temporal 
expression of the inflammatory cytokines TNF-α and IL-6, as well as Cox-2, following 
exposure to Mn and/or LPS, we quantified TNF-α, IL-6, and Cox-2 mRNA at 1 and 4 h 
post exposure.  Mn exposure by itself did not affect TNF-α mRNA at either time point 
(Figures 3.6A and 3.6B).  Exposure to LPS, on the other hand, significantly increased 
TNF-α mRNA about 100-fold at 1 h in comparison to control, and this effect diminished 
by 4 h (Figures 3.6A and 3.6B).  Similar to the effect observed with LPS alone, Mn+LPS 
significantly increased TNF-α mRNA at 1 h, with the effect of Mn+LPS on TNF-α 
expression being moderately greater than the effect of LPS alone (Figure 3.6A).  While 
the LPS effect diminished substantially by 4 h, the Mn+LPS effect persisted, thus 
allowing for much  greater TNF-α mRNA levels at 4 h in the Mn+LPS group compared 
to the LPS alone treatment (Figure 3.6B). 
In accord with the TNF-α mRNA data, LPS significantly increased expression of 
IL-6 mRNA at 1 h and 4 h (Figures 3.6C and 3.6D).  Similar to TNF-α, no effect on IL-6 
mRNA expression was observed following exposure to Mn alone (Figures 3.6C and 
3.6D).  Interestingly, although Mn+LPS increased IL-6 expression at 1 h, in contrast to 
the effect of Mn+LPS on TNF-α, this effect was not greater than the effect of LPS alone 
(Figure 3.6C).  However, similar to TNF-α, the expression of IL-6 mRNA in cells 
exposed to Mn+LPS increased over time from 1 to 4 h, almost 10-fold (Figure 3.6D).  
This effect was specific for Mn+LPS, as IL-6 mRNA in LPS-alone exposed cells, 
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although significantly greater than vehicle, did not increase between the 1 and 4 h time 
points (Figures 3.6C and 3.6D). 
As recent data have suggested that non-cytokine inflammatory molecules, such as 
prostaglandin E-2 (PGE2), may be important in Mn-induced inflammation (Liao et al., 
2007), we also quantified Cox-2 mRNA in the presence of Mn and/or LPS at 1 and 4 h.  
Although exposure to LPS and Mn+LPS increased the expression of COX-2 mRNA by 
20-fold at 1 h, the effect of Mn in combination with LPS was not greater than LPS alone 
(Figure 3.6E).  However, similar to TNF-α and IL-6, by the 4 h time point, Mn+LPS 
exposure had increased Cox-2 mRNA even further to 30-fold.  In contrast, the LPS-




















































































































Figure 3.6    Fold change (up/down from vehicle control) in TNF-α (A and B), IL-6 (C  
and D), and Cox-2 (E and F) mRNA expression following exposure to 250  
µM Mn, 100 ng/ml LPS, or 250 µM Mn + 100 ng/ml LPS for 1 h (left-hand  
graphs) and 4 h (right-hand graphs).  
All data points represent means ± SEM from 4 independent experiments.   
Data were analyzed with ANOVA and means were separated using Fisher’s  
LSD multiple comparison post hoc test.  Letters denote statistically  
significant difference from control and bars with different letters are  
















Previous research has demonstrated that Mn exposure, in combination with an 
flammogen, can increase the production of iNOS/NO (Chang and Liu, 1999; Barhoumi 
t al., 2004; Filipov et al., 2005; Chen et al., 2006), PGE2 (Liao et al., 2007), as well of 
e inflammatory cytokines TNF- α (Filipov et al., 2005; Chen et al., 2006) and IL-6 
Filipov et a
icroglia, t ncentrations of Mn, suggesting that 
ntiation 
ve been explored involving 
e TLR4 signaling pathway.   
Activation of macrophages and microglia by LPS is thought to occur (primarily) 
by binding of LPS to TLR4, leading to activation of intracellular kinases (i.e. MAPK) 
and transcription factors such as NF-κB (Barton and Medzhitov, 2003; Takeda and Akira, 
2004). Moreover, activation of the MAPK and NF-κB by LPS results in the production of 
inflammatory mediators such as NO and TNF-α (Lee et al., 1993; Lee et al., 1994; Bhat 
et al., 1998). In earlier studies, the effects of Mn on the production of inflammatory 
molecules by activated glia was shown to involve the activation of the transcription factor 
NF-κB (Barhoumi et al., 2004; Filipov et al., 2005; Chen et al., 2006).  Additionally, this 
effect is associated with the increased activation of MAPK (Bae et al., 2006), particularly 
p38 (Zhang et al., 2007; Crittenden and Filipov, 2008), which appears to be long lasting 




( l., 2005) by glial cells. Although Mn alone increases cytokine production in 
m he increase is small and only at high co
prior/ongoing microglial activation is necessary for Mn-potentiation of at least TNF-α 
and IL-6 to be observed (Filipov et al., 2005).  The cause of the Mn-induced pote
is not understood. However, several potential mechanisms ha
th
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 In our current study, we examin gnaling molecules that may be 
respons , 
 
l., 1997; Chan-Hui and Weaver, 1998; Zarubin and Han, 
2005). 
MAPKs, including ERK and JNK for MKK-1/2 and MKK-4, respectively (Koistinaho 
and Koistinaho, 2002).  Considering that ERK did not appear to play as important of a 
role in the enhanced TNF-α and IL-6 production by Mn as did p38 (Crittenden and 
Filipov, 2008), increased MKK-1/2 activity by Mn+LPS may only play a partial role in 
the persistent activation of p38 associated with the enhanced cytokine production we 
observed in Mn+LPS exposed microglia (Crittenden and Filipov, 2008). 
Another possible explanation for increased and/or prolonged p38 phosphorylation 
caused by Mn exposure which we investigated in this study is decreased activity of the 
ed the key si
ible for the prolonged activation of p38.  The upstream MAPKs, MKK-3 and -6
can activate p38, leading to the production of inflammatory mediators (Igarashi et al., 
2000; Fujishiro et al., 2001).  However, based on our results, the enhanced and prolonged
p38 activation observed in Mn-exposed, LPS-stimulated microglia (Crittenden and 
Filipov, 2008) is not the result of enhanced MKK-3/6 activation.  Indeed, at all time 
points examined in our study, the combination of Mn+LPS was no more effective than 
LPS alone in inducing MKK-3/6 phosphorylation. 
Although MKK-3 and -6 are considered to be the kinases primarily responsible 
for phosphorylating p38, data also suggest that MKK-1, -4, and –7 may be involved in 
p38 phosphorylation (Jiang et a
 In the present study, Mn in combination with LPS increased phosphorylation of 
both MKK-1/2 and MKK-4 above the increase caused by LPS alone.  This may 
contribute to the enhanced and prolonged p38 activation we have reported recently 
(Crittenden and Filipov, 2008).  Of note, both kinases have been shown to activate other 
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phosphatase MKP-1 which is responsible for deactivating p38.  The DUSPs, particu
MKP-1, are important regulators of the innate immune responses.  Overexpression of 
MKP-1 in macrophages has been shown to inhibit phosphorylation of MAPK and 
production of inflammatory cytokines (Chen et al., 2002; Shepherd et al., 2004; Zhao et 
al., 2005).  Conversely, reduced expression of MKP-1 results in increased productio
the inflammatory cytokines TNF-α and IL-6 (Chi et al., 2006; Hammer et al., 2006).
This observation is in line with our current findings demonstrating that exposure to Mn 










uld result in 
prolong
ibited by Mn, but Mn alone does not increase IL-6 and TNF-α (Filipov et al., 
2005). These data corroborate our previous findings where Mn alone increased p38 
activity, but did not increase IL-6 and TNF-α cytokine production and further highlight 
the fact that persistent increase of p38 activity by Mn is necessary, but not sufficient, for
the increased cytokine production previously observed (Crittenden and Filipov, 2
As TLR signaling not only promotes the expression of MKP-1 mRNA, but a
prolongs the half-life of the transcript, it was necessary to examine both protein and 
mRNA expression in the presence of Mn (Hammer et al., 2005).  Similar to results we 
obtained for MKP-1 protein, we observed a decrease in MKP-1 mRNA expression 
following exposure to Mn for 1 h.  Likewise, compared to the LPS alone treatment, 
decreased MKP-1 mRNA level following exposure to Mn+LPS was of the same 
magnitude as the decrease caused by the Mn-only treatment (as compared to vehicle 
control).  Thus, the reduction in MKP-1 mRNA and protein expression co
ed p38 activation and enhanced pro-inflammatory cytokine production, as we 
have reported (Crittenden and Filipov, 2008). 
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We believe the reduction in MKP-1 mRNA and protein at 1 h leads to prolonged 
p38 activity, which in turn stimulates feedback inhibition of the p38 pathway by 
promoting MKP-1 expression.  Indeed, activation of TLR4 by LPS has been shown
increase the expression of MKP-1 via MyD88, PKC, as well as other MAPK, including 
JNK and ERK, leading to feedback inhibition of p38 (Lang et al., 2006).  It is possible 
that the prolonged p38 activity observed in the presence of Mn, stimulates feedback 
inhibition that is not effective through the 1 h time point because of the reduced 
expression of MKP-1 caused by Mn.  However, the ‘rebound’ of MKP-1 expression 
observed at 4 h in Mn-exposed cells indicates the cell is compensating, albeit too late, 
prevent the prolonged activation of p38 and the enhanced production of inflammator
cytokines, such as TNF-α and IL-6 (Filipov et al., 2005; Crittenden and Filipov, 2008) 
and, perhaps, other inflammatory mediators, such as PGE2 (Liao et al., 2007).   











of IL-6 mRNA more than Mn+LPS at the 
es by microglia exposed to Mn+LPS for 24 h in vitro at the protein level (Filipov
et al., 2005; Crittenden and Filipov, 2008), we did not examine cytokine mRNA 
expression.  Previous studies have suggested that Mn+LPS exposure results in increased
TNF-α (Chen et al., 2006) and Cox-2 (Liao et al., 2007) mRNA expression by mixe
glial cells at 6 h post exposure. In accord with these data, compared to the effects of LPS
alone, we observed that TNF-α, IL-6, and Cox-2 mRNA levels in cells exposed to
Mn+LPS were markedly greater at 4 h post exposure. In contrast, at 1 h post exposure
except for a moderate potentiating effect on TNF-α, presence of Mn in the culture 
medium did not enhance inflammatory mediator mRNA above the effects of LPS alon











e point. However, by the 4 h time point, increased IL-6 mRNA expression 
persisted in Mn+LPS exposed cells, while the effect of LPS diminished.  Intuitive
would be reasonable to assume a correlation between an increased inflammatory 
mediator message expression and prolonged p38 activity.  Indeed, as we reported 
(Crittenden and Filipov, 2008), Mn+LPS effects on p38 were not different from these of
LPS alone at 1 h post exposure. However, by 4 h, LPS-caused activation of p38 was n
longer present, while the presence of Mn in the exposure solution maintained p38
activated state.   
Taken together, as depicted on Figure 3.7, early dysregulation of feedback control
of MAPK signaling by Mn exposure, specifically MKK-1, MKK-4, p38, and MKP-1, i
associated with enhanced inflammatory mediator mRNA expression by microglia and 
may lead to prolonged inflammation in brain tissue, resulting in excessive neuron


































Figure 3.7 The effect of Mn on selected components of the MAPK cascade.  Arrows 
indicate relative increase or decrease, with larger arrows indicating a greater 
effect than smaller arrows.   
 
 Abbreviations:  MKK-1/2 (Mitogen Activated Protein Kinase Kinase-1/2), 
MKK-3/6 (Mitogen Activated Protein Kinase Kinase-3/6), MKK-4 (Mitogen 
Activated Protein Kinase Kinase-4), ERK (Extracellular Signal-Regulated 
Kinase), p38 (p38 mitogen activated protein kinase), JNK (c-Jun N-terminal 













MANGANESE POTENTIATION OF MICROGLIAL INFLAMMATORY  
 
CYTOKINE PRODUCTION IS NOT RESTRICTED   
 





Previous studies have investigated the potentiation of lipopolysaccharide (LPS, a 
oll-like receptor [TLR] agonist)-induced inflammatory mediators, such as NO and 
ytokines (IL-6 and TNF-α) by manganese (Mn) in primary microglia, microglial cell 
nes, and mixed glial cultures.  Although the molecular mechanism(s) of the observed 
n-potentiation is not well understood, it is clear that transcription factors like NF-kB 
nd prolonged activation of mitogen-activated protein kinases (MAPK), such as p38, are 
quired.  However, Mn-potentiation in microglial cells activated by TLR ligands other 
an LPS has not been explored.  In the current study, to determine if Mn-potentiation 
as dependent on a specific TLR or TLR-associated signaling pathway, we examined 
n-potentiation of IL-6 and TNF-α in N9 microglia stimulated with ligands specific for 
TLR3 (Polyinosinic: polycytidylic acid; pI:C).  In addition, we also examined the 
volvemen
exposure) d s 











TLR4 (LPS), TLR 2 (Deoxyribonucleic acid; CpG), TLR9 (Peptidoglycan; GPG), or 
in t of p38, ERK, and JNK in the potentiating effects of Mn.  Manganese (24 h 
ose-respondantly potentiated secretion of pro-inflammatory cytokine protein
ctivated microglia.  Additionally, Mn exposure potentiated TNF-α m
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microglia activated with LPS, pI:C, CpG, or GPG at 4 h.  The production of IL-6 mRNA 
at 4 h on the other hand, was differentially ef t potentiating effect 
of Mn observed for LPS and pI:C.  Although enhanced p38 activation by Mn was 
observed at 4 h following activation by all TLR-ligands, pharmacological inhibition of 
p38, JNK, or ERK decreased IL-6 and TNF-
stimulated N9 microglia.  These results indic -potentiation is not limited to 
LPS-activated microglia, and potentiation can occur for an array of TLR-ligands working 
through at least four distinctive TLRs.  M s Mn-potentiation occurred in both 
Introduction 
Manganese (Mn), a ubiquitously distributed environmental contaminant (Aschner, 
2000), in cases of excessive exposure can induce neurotoxicity that is characterized by a 
neurodegeneration that results in psychiatric symptoms and extrapyramidal neurologic 
deficits (Dobson et al., 2004).  Although the mechanism of this neurodegeneration is 
largely attributed to the ability of Mn to stimulate the generation of cytotoxic free radicals 
(Aschner and Aschner, 1991; Gavin et al., 1999; HaMai and Bondy, 2004), it has been 
shown that neurodegeneration may also be due to the effects of Mn on the non-neuronal 
cells of the brain, astroglia and microglia.  This is relevant in the context of Mn-induced 
inflammation, as it has been shown that glia, especially activated glia, produce 
significantly more NO, TNF-α, and IL-6 when exposed to Mn (Chang and Liu, 1999; 
Filipov et al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008).  Importantly, 
fected, with the greates
α production in all Mn-exposed, TLR-
ate that Mn
oreover, a
TLR2- and TLR3-stimulated cells, the observed potentiation may not be dependent on 
the TLR2/4/9-associated adaptor molecule, MyD88. 
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increased expression of inflammatory mediators has been linked with neuronal cell injury 
and death (Liu et al., 2002; Hald and Lotharius, 2005) and with elevated inflammatory 
cytokine expression in animal models of Parkinson’s Disease (PD), as well as in th
brains of PD patients (Nagatsu et al., 2000; Sriram et al., 2002).  This is further support
by the observations that blockage or deletion of inflammatory mediators can attenua
basal ganglia neurotoxicity induced by the PD model toxicant, 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP; Sriram et al., 2002; Heales et al., 1999; Ferger et al., 
2004).     
 Inflammation, while necessary for defense and tissue growth, may cause 




ure.  In the brain, inflammatory 
ediators are produced by microglia and/or astroglia.  Once activated by inflammogens 
such as lipopolysaccharide (LPS), a known environmental contaminant (Niehaus and 
Lange, 2003), these cells have been shown to produce inflammatory mediators like nitric 
oxide (NO), reactive oxygen species (ROS), and the cytokines interleukin-6 and tumor 
necrosis factor (IL-6 and TNF-α, respectively; Chao et al., 1992; Jeohn et al., 2002a; 
Jeohn et al., 2002b; Liu et al., 2002).  Moreover, Mn has been shown to enhance the 
production of inflammatory mediators in LPS-activated glia (Filipov et al., 2005; Liu et 
al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008).  Although the mechanism of 
Mn-potentiation of inflammatory mediator production in LPS-activated glia is still being 
explored, it has been demonstrated that several key intracellular signaling molecules are 
involved, all of which are activated by Toll-like Receptors (TLR; Filipov et al., 2005; Liu 
et al., 2005; Chen et al., 2006; Bae et al., 2006; Crittenden and Filipov, 2008).   
m
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Activation of cells of the innate immune system (i.e. macrophages and microglia) 
by LPS and other inflammogens (i.e. bacterial peptidoglycan, bacterial DNA, viral RNA
is thought to be primarily dependent on the activation of TLR (Beutler, 2004; Takeda
Akira, 2004).  Perhaps the most well studied TLR activation pathway is the signaling 
initiated by binding of LPS to TLR4 (Beutler, 2004; Takeda and Akira, 2004).  Binding
of LPS to the TLR4 cell surface receptor initiates a signaling cascade via the adapto












kinases (MKK), MKK-1, -2, -3, -4, and -6, which subsequently phosphorylate their 
TLR that utilize the MyD88-dependent pathway for initiating intracellular activat
TLR2 and TLR9 when these receptors are ‘activated’ by their ligands, Gram positive 
bacterial cell wall peptidoglycan (GPG) and bacterial DNA (CpG), respectively (Beutler,
2004; Takeda and Akira, 2004).  This is in contrast to MyD88-independent TLR-
signaling that requires an alternative adaptor molecule, Toll-receptor-associated activator 
of interferon (TRIF), which is utilized primarily by TLR3 upon activation by its ligand, 
dsRNA (pI:C; Beutler, 2004; Takeda and Akira, 2004).  Although primarily signaling 
through MyD88, evidence also suggests that, in contrast to TLR2 and TLR9, some of
TLR4 signaling may be MyD88-independent (Beutler, 2004; Takeda and Akira, 2004).  
Once activated, these TLR initiate a signaling cascade that culminates with the activation
of NF-kB and the mitogen activated protein kinase (MAPK) cascade (Koistinaho and 
Koistinaho, 2002; Beutler, 2004; Takeda and Akira, 2004). 
  Activation of the MAPK cascade begins with the phosphorylation of the map 









n, as exposure to Mn 3 h 
ue 
tream’ targets, the MAPK (Koistinaho and Koistinaho, 2002; Beutler, 2004; 
Takeda and Akira, 2004).   
The MAPK are composed of three major kinases, including p38 MAPK (p38), 
extracellular signal-regulated kinase (ERK), and the stress-activated or c-Jun N-termin
kinase (JNK; Koistinaho and Koistinaho, 2002).  Indeed, this is the case for activated 
primary microglia and microglial cell lines, as LPS stimulation increases the 
phosphorylation of p38, ERK, and JNK, as well as the expression of inflammatory
mediators (Lee et al., 1993; Lee et al., 1994; Bhat et al., 1998; Chen et al., 2006).  
Furthermore, neuronal survivability in neuronal-glia co-culture is decreased in LPS-
activated microglia, an effect that can be inhibited by pretreatment with inhibitors of p
(Bhat et al., 1998; Jeohn et al., 2002a; Jeohn et al., 2002b). 
In the context of Mn-potentiation of inflammatory cytokines by LPS-stimu
microglia, we have demonstrated that potentiation is dependent on NF-kB and p38, as 
inhibitors of NF-kB and p38 were able to prevent enhanced IL-6 and TNF-α production 
in Mn+LPS cells (Filipov et al., 2005; Crittenden and Filipov, 2008).  Additionally, we
have shown that p38 phosphorylation (activation) and p38 kinase activity is prolonged in 
the presence of Mn+LPS, relative to LPS alone, suggesting that the increased 
inflammatory cytokines in Mn+LPS-exposed cells  is partly due to dysregulation of the 
p38 signaling pathway (Crittenden and Filipov, 2008).  Moreover, we have demonstrat
that this effect is independent of the timing of exposure to M
before or after LPS potentiated IL-6 and TNF-α production (Crittenden and Filipov, 
2008).  Furthermore, we have demonstrated that enhanced p38 activation is, in part, d
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to enhanced activation of ‘upstream’ MKK-1/2 and -4, as well as decreased activity o
the phosphatase, mitogen ki
f 





ajor MAPK (i.e. p38, ERK, 
and JN





Cell Culture.  For all experiments, the retroviral-immortalized brain microglial  
cell line, N9, was used.  The N9 cell line was the kind gift of Dr. P. Ricciardi-Castagnoli  
(University of Milan, Italy), and is derived from day13 embryonic mouse brain cultures.   
 
However, the potentiating effect of Mn in  microglia activated by TLR ligands 
other than LPS has not been studied and, perhaps, examining the distinctive TLR 
signaling pathways may provide information regarding the mechanism of Mn-potentia
inflammation previously observed for LPS-stimulated cells.  To address these
in this study, our objectives were to (i) determine if Mn can potentiate inflammatory
cytokine production (protein and mRNA) in N9 microglia stimulated with TLR-liga
other than LPS, (ii) if Mn-potentiation is observed for TLR-ligands other than LPS, 
determine whether p38 activation is associated with the Mn-potentiation, and (iii) using 
pharmacological inhibition, determine the role of the three m
K) for each Mn-TLR ligand combination. 
 
 
Chemicals.  Manganese (MnCl2; 1 M stock) was purchased from Sigma-Aldrich
(Sigma; St. Louis, MO) with purity >99.9 %, and was used for all experiments.  TLR 
ligands utilized in this study were lipopolysaccharide (LPS, Escherichia coli 0
Sigma), Polyinosinic-polycytidylic acid potassium salt (pI:C; Sigma), Peptidoglycan 





The N9 cell line is similar to another cell line, N13, as well as primary microglia, in tha

















bated for up to 24 h in the presence of  
 
Mn (100 or 250 µM), Gram negative bacterial Lipopolysaccharide (LPS, Escherichia coli  
 




ctivated by LPS (Righi et al., 1989; Heyen et al., 2000). 
All cultures were maintained at 37° C (5% CO2 with 95% air) in RPMI-16
supplemented with 10%  FBS (low endotoxin, ≤ 25 EU/ml; Hyclone, Logan, UT),  
0.075% sodium bicarbonate, 1 mM sodium pyruvate, 1 mM non-essential amino acids, 2 
mM L-glutamax, 50 µM 2-mercaptoethanol, 25 µg/ml gentamycin, 100 U/ml penicill
G, and 100 mg/ml streptomycin (all from Invitrogen, Carlsbad, CA).  For  
pharmacological inhibition and cytokine studies, cells were seeded at 0.25 x 106  
cells/well (0.5 ml volume) in 48-well plates (Costar; Fisher Scientific, Pittsburgh, PA).   
For western blot and mRNA analysis, cells were seeded at 2.5 x 106 cells/well (5 ml  
volume) in 6-well plates (Costar).  Cells were incu
0 µg/ml), Gram positive bacterial peptidoglycan (GPG, Staphylococcus aureus; 5  
 







The Mn and LPS exposures used in this study were consistent with reported  
environmental exposures and previous studies as described in previously published wo
(Crittenden and Filipov, 2008). 
 
Cytokine Analysis.  To quantify the amounts of IL-6 and TNF-α, we used  
DuoSet ELISA kits from R&D Systems, Inc, Minneapolis, MN) and manufacturer’s  
 
instructions were followed.  Briefly, 96-well microplates (Costar) were coated for  
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overnight at 4 C with their respective capture antibody in PBS.  The plates were then  
 
washed with PBS-Tween buffer (3x) and blocked (1% BSA in PBS) for 1 h at RT.  Then,  
ubated for 2 h at RT.   




 and  
Pharmacological manipulation.  For pharmacological inhibition of p38, JNK,  
nd ERK, the inhibitors SB203580, SP600125, and UO126, respectively, (Calbiochem,  
an Diego, CA), were added 1 h prior to exposure to Mn and/or TLR ligand.  The  
hibitors were dissolved in DMSO (25.4 mM) and stored and –80°C until diluted to a  
orking concentration of 2.5 mM prior to use.  For actual experiments, inhibitors were  
iluted in the culture media to the final concentration of 25 µM.  Thus, exposure to  
MSO was at 0.1% for vehicle and MAPK-inhibitor exposed cells and it had no effect  
n cellular function. 
qPCR analysis of IL-6 and TNF-α.  Gene expression for IL-6 and TNF-a was  
 
etermined using qPCR.  Briefly, total RNA was isolated using the RNeasy Mini Kit  
iagen, Valencia, CA) and all samples were treated with DNase to remove any  
ontaminating genomic DNA.  Total RNA was quantified using the NanoDrop  
 
the samples or standards were applied to individual wells and inc
 
he plates were washed 3x, incubated with detection antibody for 2 h, followed b
another 3x wash.  Strepavidin-HRP conjugate was added to each well for 20 min at 
 
plates were washed 3x, and TMB-based substrate was added to each well and allowed to  
 
develop up to 30 min.  To stop the reaction, 50 µl of 2N H2SO4 was added to each well  
 
and the absorbance was read using a Spectramax Plate Reader (Molecular D
 
Sunnyvale, CA) at 450 nm.  For each cytokine, samples were assayed in duplicate
 


























Spectrophotometer ND-1000 (NanoDrop Technologies, Inc.) and 1 µg of total RNA was  
sed to synthesize the first strand cDNA with the RT2 PCR Array First Strand Kit  
uperArray Bioscience Corporation, Frederick, MD).  Starting with 10 ng of RNA per  
mple, expression of the cytokines IL-6 and TNF-α was determined by qPCR (iCycler  
, Bio-Rad) using mouse specific primers (SuperArray).  Each reaction mixture was  
ombined within an individual well of a 96-well plate using the RT-PCR SYBR Green  
aster Mix (SuperArray) and amplifications were performed using an iCycler iQ (Bio- 
ad).  Reactions were amplified using an initial step of 30 min at 50 °C and 10 min at 95  
°C for 15 s and 1 min at 60 °C.  To determine the quality  
f the products, a melting curve program was ran after the cycling program.  For  
determ   
own  
Immunoblot Analysis of p38 MAPK  Following incubation for 1 or 4 h, cells  
ere removed by scraping, centrifuged at 300 xg for 10 min a 4 °C, resuspended in 100  
























ination of baseline message expression, the expression of the house-keeping gene
 
GAPDH was verified as not being affected by vehicle/Mn/LPS treatment.  Data are  
 
presented as relative induction (fold-change) of pro-inflammatory cytokine.  Data sh
 
are representative of up to four independent experiments and measurements were  
 








 deoxycholate, 0.1% SDS) containing PMSF (Sigma), protease and phosphatase  
 
inhibitors (Protease Inhibitor Cocktail, Sigma, and HALT Phosphatase Inhibitor Cockt
 
Pierce, [Rockford, IL], respectively), and held on ice for 30 min with occasional p
 
to disrupt cell membranes.  The cell lysate protein concentration was determined
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the Bradford method with reagents obtained from Bio-Rad and with bovine serum  
 
albumin (BSA) as a standard.  Sample aliquots were denatured in reducing  
 
sample buffer by heating for 5 min at 95 °C.  Samples were electrophoretically  
 
separated by loading 20 µg of total protein per well in a 10% SDS-PAGE gel, transferred  
 goat  








All membranes were incubated overnight at 4 °C with antibody specific for  
 
phosphorylated p38 MAPK (1:500) or non-phosphorylated p38 MAPK (1:3000) (Cell  
 
Signaling Technology, Beverly, MA).  Following incubation, each membrane was rinsed  
 
(3x) and washed (4x) for 15 min per wash.  Then, each membrane was probed with
 
anti-rabbit secondary antibody conjugated with horseradish peroxidase (1:10,000, Bio- 
 
Rad) for 1.5 h at RT.  Next, the blots were exposed to SuperSignal West Pico  
 
chemiluminescent substrate (Pierce) for up to 5 min and then enclosed in transparent  
 





Statistical Analysis.  Data were analyzed using appropriate analysis of variance 
 
(ANOVA).  When statistical differences were detected (P < 0.05), treatment means were 
 







 CpG, or GPG, alone or in combination with Mn (100 or 250 µM), for 24 h.  As 
previou ), 
 
pI:C at the 
ligands 
els of cytokine observed in 
I:C and LPS exposed cells (Figure 4.1B). 
Co-exposure to Mn (100 or 250 µM) and LPS, pI:C, CpG, or GPG potentiated 
NF-α and IL-6 in a dose-responsive manner (Figures 4.1A and 4.1B).  The most 
rofound effect on TNF-α potentiation was observed in cells co-exposed to 250 µM Mn 
and CpG or GPG with a 3-fold increase in TNF-α compared to TLR ligand alone, 
although significant potentiation of TNF-α by Mn was observed for LPS and pI:C as well 
(Figure 4.1A).  Manganese potentiated IL-6 production for all TLR ligands (LPS, pI:C, 
 
IL-6 and TNF-α protein expression.  To determine whether Mn can
inflammatory cytokine production by microglia activated by different TLR ligan
similar to the effects of Mn on LPS-activated microglia as we have previously reported 
(Filipov et al., 2005; Crittenden and Filipov, 2008), we exposed N9 microglia to LPS, 
pI:C,
sly reported, except for a small increase TNF-α by Mn (250 µM; Figures 4.1A
neither vehicle nor Mn alone induced significant cytokine (Figures 4.1A and 4.1B; 
Filipov et al., 2005; Crittenden and Filipov, 2008).  Inflammatory cytokine (IL-6 and 
TNF-α) production was significantly increased in microglia exposed to LPS, pI:C , CpG, 
and GPG (Figures 4.1A and 4.1B).  The increase in media TNF-α levels was highest for
cells exposed to LPS and pI:C (Figure 4.1A).  While not as effective as LPS or 
concentrations used, CpG and GPG also significantly increased microglial TNF-α 
production (Figure 4.1A).  Similar results were observed for IL-6, as all four TLR 





CpG, GPG), with the greatest effects observed for 250 µM Mn in combination with pI:C  
or CpG, with overall increases of 3- and 4-fold (respectively) in comparison to the TLR 

































Figure 4-1      Effect of exposure to manganese (Mn) and/or lipopolysaccharide (LPS),   
 polyinosinic:polycytidylic acid (pI:C), peptidoglycan (GPG), microbial  
 DNA (CpG) on microglial inflammatory cytokine production.   
 
 TNF-α (1A) and IL-6 (1B) production was analyzed in supernatants  
 collected 24 h after exposure to N9 microglial cells to Mn (100 or 250 µM),  
 and/or LPS (100 ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG (5 µg/ml).   
 Media levels of TNF-α and IL-6 were analyzed by respective DuoSet  
 ELISA as described in Materials and Methods.  Data shown in each bar  
 represent the mean ± SEM, of 4 independent replicates. a,b,c Presence of  
 letters on top of bars indicate treatment differences relative to vehicle/Mn  
 250 or within a particular TLR ligand-Mn combination for TNF-α (1A) and  
 IL-6 (1B) levels with bars with different letters being different from each  
 other and from bars without a letter (p ≤ 0.05).  # Indicates significant  





















































































































IL-6 and TNF-α mRNA expression.  To determine whether Mn-potentiation of 
TNF-α nd IL-6 occurred at the level of mRNA transcription, inflammatory cytokine 
RNA expression was quantified using q-PCR.  The TLR ligands alone significantly 
creased TNF-α and IL-6 mRNA expression, respectively (Figure 4.2A and 4.2B, 
spectively).  
Manganese potentiated TNF-α mRNA expression for all TLRs at 4 h (Figure 
.2A).  The highest TNF-α mRNA potentiation by Mn was observed for LPS and pI:C 
.5 and 4-fold increases, respectively), with a smaller, but significant, increase observed 
r CpG and GPG as well (Figure 4.2A). Somewhat in contrast to TNF-α mRNA 
duction, IL-6 mRNA expression was significantly potentiated by Mn in only the LPS- 
nd pI:C-exposed cells, while the Mn-potentiation observed in CpG- or GPG-stimulated 

























































































Figure 4.2     Fold change (up/down from vehicle control) in TNF-α (A) and IL-6 (B)  
 mRNA expression following exposure to 250 µM Mn and/or LPS (100  
 ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG (5 µg/ml).   
 
 All data points represent means ± SEM from 3 or more independent  
 experiments.  Data were analyzed with ANOVA and means were separated  
 using Fisher’s LSD multiple comparison post hoc test.  a,b Letters denote  
 statistically significant difference at p ≤ 0.05 and represent differences from  




 Immunoblot analysis of p38 and phospho-p38 protein.  To examine p38 
activation, we measured p38 phosphorylation (normalized to non-phosphorylated p38) 
following exposure to TLR-ligands alone, or in combination with 250 µM Mn at 4 h.  
Similar to previously published data (Crittenden and Filipov, 2008), LPS-induced  p38 
phosphorylation had subsided  by 4 h and was not different from control, while 250 µM 
Mn- or 250 µM Mn+LPS-induced p38 phosphorylation was still significantly increased 
in comparison to vehicle control (Figure 4.3A ).  Similar to LPS alone at 4 h, pI:C, CpG, 
or GPG-induced p38 phosphorylation was not different from control  (Figure 4.3A).  
However, significantly increased p38 phosphorylation was observed for 250 µM Mn in 
combination with pI:C, CpG, or GPG,  with the largest increase being a 5-fold increase in 
p38 phosphorylation for CpG (Figure 4.3A ).  The levels of non-phosphorylated p38 (all 
exposures) did not significantly change in response to Mn and/or TLR ligands (Figure 
4.3A).   
In comparison to previous work examining the effect of 1 h exposure to Mn and 
tion 
 N9 microglia exposed to Mn and another TLR ligand, pI:C, for 1 h.  Co-exposure to 
n and pI:C
similar between the two (Figure 4.3B). Furthermore, in agreement with previously 
ublished data for Mn and LPS (Crittenden and Filipov, 2008), the p38 phosphorylation 
in microglia exposed only to pI:C diminished by 4 h (Figure 4.3A).  
 
LPS on p38 activation (Crittenden and Filipov, 2008), we quantified p38 phosphoryla
in
M  significantly increased p38 phosphorylation relative to pI:C alone, while the 































































Figure 4-3     Analysis of phosphorylated p38 kinase in N9 microglia exposed to (A)  
 
 Western blots and densitometric analysis were performed as described in the  
 adjusted pixel density for phosphorylated p38 normalized to the  
 to the legend on  
 Fig.4-1.  Each bar represents a minimum of 3 independent replicates. 
  a,b Letters denote statistically significant difference at p ≤ 0.05 and represent  






 250 µM Mn and/or LPS (100 ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG 
 (5 µg/ml) for 4 h or (B) 250 µM Mn and/or pI:C (50 µg/ml) for 1 h.   
  
 Materials and Methods.  Data shown represent the means ± SEM of the  
 non-phosphorylated p38.  For abbreviations please refer
 ___  ___  __________ __________ 
 Veh  Mn         pI:C         Mn+pI:C 
 ___  ___  __________  __________ 
 Veh  Mn       GPG           Mn+GPG 
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F 3 (continued)  4-
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Effect of MAPK inhibitors on cytokine expression.  To determine whether p38, 
JNK, or ERK MAPK are required for Mn-potentiation of TNF-α or IL-6 in TLR-
ctivated microglia, N9 cells were pretreated with inhibitors specific for either p38, JNK, 
r ERK. As previously observed, p38 inhibition prevented both LPS-induced TNF-α 
rotein expression, as well as Mn-potentiation of LPS-induced TNF-α production (Figure 
.4A).  Similarly, inhibition of JNK and ERK also prevented LPS-induced TNF-α 
roduction, as well as Mn+LPS-induced TNF-α production (Figure 4.4A).   
 As observed with LPS-stimulated microglia, production of TNF-α in microglia 
imulated with CpG- or GPG-alone, or in the presence of Mn, was significantly inhibited 
y all three inhibitors, with the greatest effect observed for JNK- and ERK-inhibitors 
ith near complete inhibition (Figures 4.4C and 4.4D).  Unlike the previous TLR ligands 
PS, CpG, and GPG), inhibition of TNF-α production in pI:C- or Mn+pI:C-activated 
ells was greatest following inhibition of JNK or ERK, although all three inhibitors were 
ffective (Figure 4C). 
As we have also previously observed for IL-6, prior exposure to SB203580 
-6 production in LPS- and Mn+LPS-exposed cells (Figure 
4.5A).  However, SP600125 and UO126 were the most effective at inhibiting IL-6 
production in LPS-stimulated cells (Figure 4.5A).  Similar to the inhibition observed with 
LPS-stimulated cells, all MAPK inhibitors were effective at preventing IL-6 production 
in CpG- or GPG-stimulated N9 microglia, with the greatest effect observed for SP600125 

















80, SP60025, or UO126 prevented pI:C and Mn+pI:C-induced IL-6 production, 






























































































































































































































































Figure 4.4 Effect of exposure to SB203580 (SB, p38 inhibitor), SP600125 (SP, JNK  
 inhibitor), and UO126 (UO, ERK inhibitor) on Mn-potentiation of LPS,  
 pI:C, CpG, or GPG-activated microglial TNF-α production.  
 
 TNF-α production was analyzed in N9 microglia exposed for 1 h to 25  
 µM of SB, JNK, or ERK, followed by exposure to 250 µM Mn and/or  100  
 ng/ml LPS (A), 50 µg/ml pI:C (B),  200 nM CpG (C), or 5 µg/ml GPG  
 (D).   Media levels of TNF-α and IL-6 were analyzed by respective  
 DuoSet ELISA as described in Materials and Methods.  Data shown in  
 each bar represent the mean ± SEM, of 4 independent replicates. a,b,c,d,e,f,g  
 Presence of letters on top of bars indicate treatment differences in the  
 TNF-α levels with bars with different letters being different from each  

















igure 4.5 Effect of exposure to SB203580 (SB, p38 inhibitor), SP600125 (SP, JNK  









































































































































































































































 inhibitor), and UO126 (UO, ERK inhibitor) on Mn-potentiation of LPS,  
 pI:C, CpG, or GPG-activated microglial IL-6 production.  
 
 
 of SB, JNK, or ERK, followed by exposure to 250 µM Mn and/or  100  
 ng/ml LPS (A), 50 µg/ml pI:C (B),  200 nM CpG (C), or 5 µg/ml GPG  
 (D).  Media levels of IL-6 were analyzed by respective DuoSet ELISA a
 described in the Materials and Methods.  Data shown in each bar repr
 the mean ± SEM, of 4 independent replicates.   . a,b,c,d,e,f,g Presence of  
 letters on top of bars indicate treatment differences in the IL-6 levels with  
 bars with different letters being different from each other and from bars




 Several previous studies have shown that Mn can enhance, or potentiate, LPS-
induced inflammatory mediator production in glial cells (Chang and Liu, 1999; Filipov et 
al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008).  Additionally, it has been 
demonstrated that Mn-potentiation of neuroinflammation is dependent on NF-kB, and is 
associated with persistent p38 activation (Filipov et al., 2005; Crittenden and Filipov, 
2008).  However, it is not clear if these effects are limited to a specific inflammagen (i.e. 
LPS) or activating receptor/pathway (i.e. TLR4).  It has already been shown that primary 
microglia, both human and murine, produce TNF-α and IL-6 in response to stimulation 
with GPG, pI:C, LPS, and CpG which are ligands for TLR 2, TLR3,TLR4, and TLR9, 
respectively (Olson and Miller, 2004; Jack et al., 2005; Town et al., 2006).  In the current 
study, following TLR stimulation, we observed similar increases in TNF-α and IL-6, as 
was observed for primary microglia (Olson and Miller, 2004; Jack et al., 2005; Town et 
al., 2006), suggesting that this (N9) cell line behaves similar to primary microglia.  




ach cytokine estingly, although Mn-potentiated TNF-α 
mRNA for LPS, pI:C, CpG, and GPG-stimulated cells, IL-6 mRNA was only statistically 
M
occur in TL timulated N9 microglia for several TLR ligands, but that it does so in a 
dose-responsive manner (Figures 4.1 and 4.1B).  Importantly, this suggest
potentiation is not dependent on MyD88, a common signaling adaptor for TLR2, TLR4, 
and TLR9, but not TLR3. 
 , the increase in TNF-α and IL-6 due to the combination of Mn+TLR-
ligand is not limited to protein expression, as increased mRNA was observed at 4 h for 
e (Figures 4.2A and 4.2B).  Inter
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om that of LPS.  Increased phosphorylation of p38 was 
ss 
 
potentiation of CpG- and GPG-induced IL-6 production may not be entirely due to 
enhanced transcription of IL-6 mRNA.  It should be noted that Mn alone did not increase 
cytokine protein or mRNA (Figures 4.1 and 4.2) to any major extent, suggesting that M
potentiation of TLR-induced cytokine mRNA and protein expression requires activation 
of a TLR-signaling pathway by a TLR agonist. 
 Previously, we have reported that Mn-potentiation of LPS-induced inflammatory 
cytokine production is associated with prolonged p38 activity (Crittenden and Filipov, 
2008).  In the present study, p38 phosphorylation was greatest in Mn+TLR-ligand 
exposed cells.  Furthermore, the increased p38 phosphorylation persisted up to 4 h after
initial exposure, unlike the TLR-ligands alone which were not significantly increased at 4 
h in comparison to vehicle control (Figures 4.3A).  Of note, no significant differences 
were observed for non-phosphorylated p38 for any of the TLR-ligands, alone or in 
combination with Mn, which suggests the observed increase in p38 activation was n
associated with changes in protein expression for p38 (Figure 4.3A).   
As we have also previously reported, p38 phosphorylation in response to LPS 
stimulation is elevated at 1 h, but diminishes by 4 h (Crittenden and Filipov, 2008).  I
this study, we examined p38 phosphorylation at 1 h for another TLR ligand, pI:C, which 
has differential signaling fr
observed at 1 h for pI:C-stimulated N9 microglia relative to vehicle, however it was le
than Mn and pI:C in combination (Figure 4.3B).  Similar to LPS alone as previously 
reported (Crittenden and Filipov, 2008), pI:C-induced p38 phosphorylation decreases by
4 h, suggesting that prolonged p38 phosphorylation is important for the enhanced 
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inflammatory cytokine production observed for the pI:C-Mn combination and m
important for Mn-potentiation of  CPG- and GPG-induced TNF-α and IL-6 as well. 
The relevance of the previous observations is underscored by the fact that each 
TLR (i.e. TLR2, TLR3, TLR4, and TLR9) utilizes somewhat different signaling 
pathways (Beutler, 2004; Takeda and Akira, 2004).  In the case of pI:C, a distinctly 
different pathway is utilized, as pI:C-TLR3 sign
ay be 




e have previously 
demons , 
d glia 
 It has 
the TRIF adaptor molecule instead (Beutler, 2004; Takeda and Akira, 2004).  Thus, the 
Mn-potentiation effect is not dependent on a specific signaling pathway.  As Mn 
potentiates pI:C-induced TNF-α and IL-6, it seems likely that Mn-potentiation of T
induced inflammatory cytokine production is independent of MyD88.  However, as CpG
and GPG-signaling occurs through TLR9 and TLR2 (respectively), and since both of 
these TLRs are believed to require the adaptor molecule MyD88 (Beutler, 2004), Mn-
potentiation may utilize either MyD88 or TRIF. 
Another likely target for Mn-potentiation of microglial inflammatory cytokines 
the family of ‘downstream’ signaling kinases, p38, ERK, and JNK.  W
trated that pharmacological inhibition of p38, and to a much lesser degree ERK
prevented enhanced inflammatory cytokine production in Mn+LPS-exposed N9 
microglia (Crittenden and Filipov, 2008).  Additionally, research by Chen et al. (2006) 
reported not only Mn-potentiation of TNF-α in LPS/IFN-γ-stimulated primary mixe
and increased phosphorylation of multiple (p38, ERK, JNK) kinases, but also that 
pharmacological inhibition of p38 prevented the potentiating effect of Mn.  .      
While our previous data regarding p38 activation is in agreement with others 
(Chen et al., 2006), we have not extensively examined the role(s) of ERK or JNK. 
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been reported that inhibition of ERK by UO126 was effective at preventing Mn-












r, PD98059, which was not as effective as the p38 inhibitor SB203580 at 
preventing Mn-potentiation.  As the ERK inhibitor PD98059 prevents activation o
inactive MKK ‘upstream’ of ERK, but not the activated MKK (Favata et al., 1998), i
possible that incomplete inhibition of the MKK responsible for phosphorylating ERK 
may have underplayed the role of ERK in IL-6 and TNF-α production in Mn+LPS-
exposed cells.  To that end, using the ERK inhibitor UO126 that is reported to inh
both inactive and active MKK (Favata et al., 1998) may provide more information 
regarding the role of ERK in Mn-potentiation of TLR-induced cytokine production.  
Additionally, although it has been demonstrated that the JNK inhibitor SP600125 can 
prevent inflammatory cytokine synthesis in cells of the innate immune system, we hav
not previously examined this role of the JNK sign
 and IL-6 by TLR-stimulated N9 microglia (Waetzig et al., 2005; Zhou et al., 
2007).   
 To determine if ‘partial’ ERK inhibition may have been responsible for the 
incomplete inhibition of Mn-potentiation that we previously observed in our expe
model, as well as to examine the role of JNK, we exposed N9 microglia to inhibitors for
p38, JNK, and ERK prior to exposure to Mn and/or TLR-ligands (LPS, pI:C, CpG, or 
GPG).  Although all MAPK inhibitors (SB203580, SP600125, and UO126) were 
effective at preventing Mn-potentiation of TNF-α or IL-6, we observed a differen
f MAPK inhibition among the TLR tested.  Inhibition of Mn-potentiation for 
TNF-α and IL-6 in TLR2, TLR4, and TLR9-stimulated cells was greatest for the JNK 
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and ERK inhibitors, in contrast to TLR3 where p38 and JNK inhibition was most
effective.   
For TLR4 (LPS), this is somewhat in contrast to our previous work, but in
agreement with Chen et al. (2006) who reported that prior exposure to SB203580, 
UO126, or SP600125 inhibited LPS- and Mn+LPS+IFN-γ-induced TNF-α production by
mixed glia equally (Chen et al., 2006).  In the case of ERK, this may be due to the 
differences in the mechanism of action of the MAPK inhibitors (PD98059 vs. UO12
Although the role of the MAPK in Mn-potentiation of TLR2 and TLR9-induced 
inflammatory cytokines had not been previously examined, the inhibition of Mn-
potentiated, TLR (CpG or GPG)-induced TNF-α and IL-6 expression in microglia pre
incubated with p38, JNK, or ERK inhibitors is not unprecedented, as the TLR2, TLR4,
and TLR9 receptors use a similar signaling pathway (i.e. MyD88-dependent pathway; 
Takeda and Akira, 2004; Beutler, 2004).   It is possible that inhibiting a target 













On the other hand, inhibition of JNK and ERK in CpG- or GPG-stimulated c
was more effective at preventing cytokine expression than p38 inhibition, as inhibition of 
JNK and ERK almost completely inhibited TNF-α and greatly reduced IL-6.  This was 
not the case with TNF-α and IL-6 production in cells exposed to SB203580 followed b
Mn+TLR (i.e. LPS, CpG, GPG), in that cytokine production was significantly inhi
but not as much as with SP60125 and UO126.  This could be explained by the 
observation that both TLR2 and TLR9 require MyD88 for intracellular signaling, whi
TLR4 can initiate intracellular signaling by a MyD88-dependent or –independent 
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pathway (Beutler, 2004; Takeda and Akira, 2004).  It may be that MyD88-mediate
signaling by
d 










ell as in 
r 4-signaling, on the other hand, can initiate signaling by two different pathw
which increases the diversity of ‘downstream’ targets (Barton and Medzhitov, 2003
Beutler, 2004).  Thus, TNF-α production in TLR4-stimulated cells is less dependent on 
individual intermediate signaling molecules (i.e. p38, JNK, or ERK). 
Interestingly, Mn-potentiation of TLR3 (pI:C)-induced TNF-α and IL-6 is most 
sensitive to inhibition of p38 and JNK.  As TLR3 is believed to be MyD88-indep
it may be that this signaling pathway primarily uses p38 and JNK to mediate intra
signaling (Takeda and Akira, 2004; Beutler, 2004).  However, as was observed overall 
for TLR2, TLR4, and TLR9-stimulated cells, inhibition of all three MAPKs was at least
partially effective in preventing enhanced inflammatory cytokine production.  
In summary, Mn-potentiation of TLR-induced inflammatory cytokines 
limited to LPS-stimulated microglia, and Mn-potentiation can occur for a broad arra
TLR (i.e. pI:C, CpG, and GPG).  Manganese-potentiation is not MyD88-depend
 and IL-6 production is potentiated in TLR3 (pI:C)-stimulated microglia, which is 
a MyD88-independent signaling pathway.  Prolonged p38 phosphorylation is associated 
with Mn-potentiation in TLR (LPS, pI:C, CpG, GPG)-stimulated N9 microglia.  
Pharmacological inhibition of p38, ERK, and JNK inhibited inflammatory cytokine 
production in all TLR (LPS, pI:C, CpG, GPG)-stimulated cells, suggesting one or more 
of the MAPK are involved in TLR-mediated  TNF-α and IL-6 production, as w













ifferent cell types 
within e 
ge and 
death.   as 
tential 
erved in LPS- or LPS/INF-γ-activated glia.  
Indeed, production of cytokines and NO in LPS-activated microglia is potentiated by Mn, 
the multicellular milieu of tissues and organs.  The exchange of information in th
form of neurotransmitters, hormones, cytokines and many other biomolecules, in 
appropriate concentrations and duration, allows cells to promote growth and development 
within the tissue and between organs, thereby promoting the fitness of the organism.  
However, excessive or prolonged expression of these molecules, as observed with 
inflammation, may be detrimental to cells and tissues, promoting cellular dama
Interestingly, the latter concept is similar to a fundamental tenet of toxicology,
the difference between a cure and a poison is attributed to the dose a chemical (reviewed 
in Ames and Gold, 2000).  In the current study, we have attempted to address how 
exposure to a toxicologically relevant metal, such as Mn, results in enhanced and 
prolonged expression of inflammatory cytokines, with an emphasis on intracellular 
signaling, as this may provide insight into the mechanism of action, as well as po
targets for therapeutic intervention in cases of excessive Mn exposure. 
 Although it has been reported that Mn alone can induce mild to moderate 
expression of inflammatory mediators in non-activated glia (Bae et al., 2006; Zhang et 
al., 2007), the greatest effect has been obs
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typically resulting in 2-fold or more increase in inflammatory mediators relative to LPS 
alone (Barhoumi et al., 2004; Filipov et al., 2005; Crittenden and Filipov, 2008).  
However, whether Mn-potentiation is dependent on activation of the TLR4-signaling 
pathway, or a specific molecular component, is not clear.  To demonstrate that Mn-














potentiation of microglial cytokine production can occur in cells activated by pI:C, CpG,
or GPG, ligands for TLR3, TLR2, and TLR9, respectively  (Figure 4.1).  Additionally, 
we have demonstrated that the potentiation is not dependent on time of exposure, a
exposure to Mn 3 h before or after microglial activation will result in enhanced IL-6 and 
TNF-α production (Figure 2.1).   Taken together, Mn-potentiation is not dependent on
activation by a specific TLR ligand (i.e. LPS, pI:C, CpG, or GPG) and is not limite
narrow window of exposure, suggesting that exposure to Mn could occur before or afte
exposure to various TLR ligands. 
 On the other hand, activation of the CNS inflammatory cells may not be 
dependent on direct stimulation of microglial TLR.  It has been shown that peripher
inflammation can induce activation of cellular inflammation in the CNS (Perry et a
1998; Cunningham et al., 2005).  It is possible that induction of peripheral inflamma
can trigger neuroinflammation and, if Mn exposure has occurred/is occurring as well, the
result could be an enhanced and prolonged inflammatory cytokine prod
brain.  Although an intriguing hypothesis, there is no published data to support thi
possibility at the present time. 
 As the first reports to describe the potentiation effect were in glia co-exposed to
Mn and LPS, with or without IFN-γ, (Spranger et al., 1998; Chang and Liu, 1999; 
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Barhoumi et al., 2004), the TLR4 signaling pathway appeared to be the logical candidate 
for the site of action of Mn.  Some of the early studies clearly demonstrated a role 
transcription factors like NF-kB, as well as signaling kinases like the MAPK, which ar
both components of the TLR4 signaling pathway (Chang and Liu, 1999; Filipov et a
2005; Bae et al., 2006; Crittenden and Filipov, 2008).  Therefore, we initially e
two of the MAPK thought to be critical for production of inflammatory mediators by 
microglia, p38 and ERK (Koistinaho and Koistinaho, 2002).  We investigated the role o
p38 and ERK using pharmacological inhibitors specific for each of these MAPK, 
SB203580 and PD98059, respectively.  From this work, we concluded that p38, and not 
ERK, was primarily responsible for the Mn-potentiation we had observed.  This data w
in general agreement with the perceived role of p38 in stress and inflammation, while 
ERK appeared not to be as important in the observed Mn-potentiation (Koistinaho and 









n-potentiation, pharmacological inhibition of any of the 
ree m
, 
However, published work by others using mixed glia or primary microgli
suggested that, besides p38, JNK and ERK were also involved in the production of 
inflammatory mediators by microglia (Bae et al., 2006; Liao et al., 2007; Zhang et al., 
2007).  Since we had not previously examined the role of JNK in our experimental 
system, we decided to assess the role of JNK using pharmacological inhibition (i.e. 
SP600125), as well as re-examine the role of ERK using a different pharmacological 
inhibitor, UO126. Although our early investigations suggested that p38 was, perhaps
most involved in the observed M
th ajor MAPK prevented both TLR- and Mn+TLR-induced inflammatory cytokine 
expression.  This work was somewhat in contrast to our previous findings with ERK
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which may be due to incomplete inhibition of ERK by PD98059 as it only targets 
inactive ERK, while UO126 inhibits both inactive and active ERK (Favata et al., 1998
Additionally, both SB203580 (p38) and SP600125 (JNK) prevented Mn-potentiation in 
LPS-activated N9 microglia. 
Taken together, pharmacological inhibition of the MAPK (i.e. p38, ERK, or JNK)
will inhibit Mn-potentiation in TLR-activated N9 microglia.  Although p38 may not b
the only MAPK involved in the Mn-potentiation of inflammatory cytokines, activation of 
p38 and its downstream targets like the cytokine transcription factor TATA-bindin
protein (TBP), as well as activation of NF-kB, is necessary for TNF-α expression (Carter
et al., 1999).  We have demonstrated that Mn exposure not only increases p38 activation 
(i.e. phosphorylation), but also increases p38 kinase activity in LPS-activated N9 
microglia.  Moreover, as p38 kinase activity is responsible for activating transcription 










anced p38 phosphorylation and kinase activity may result in increased 
inflammatory cytokine mRNA and protein expression.  Indeed, we have observed M
dependent increases in TNF-α mRNA and protein expression in LPS-activated N9 
microglia.  However, it is not clear if Mn effects TBP activation and/or nuclear 
translocation, as we have not examined activation of TBP at this time. 
On the other hand, the role of JNK and ERK cannot be overlooked, as these 
MAPK play a role in the expression of inflammatory mediators by activated microglia
(Waetzig et al., 2005; Wu et al., 2007).  Although our current data is in general 
agreement with the literature, it is not clear if one or more of the MAPK is of greater 
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importance than the others in the Mn-potentiation of inflammatory mediators we h
observed. 
Another important question is what is responsible for the enhanced and prolonged
activation of p38, and perhaps
ave 
 












MKP-1 expression coincides with p38 activation, to serve as feedback control, thereby 
pendent on the upstream MAP2K, we have examined the MAP2K primarily 
responsible for activating p38, MEK-3/6.  In addition, we have examined two other 
MAP2K that may be important in the activation of p38, as well as ERK and JNK, MEK-
1/2 and MEK-4, respectively.  Although MEK-3/6 activation was not significantly 
changed by the presence of Mn, we did observe a small but significant increase in the 
phosphorylation of MEK-1/2 and MEK-4 at 1 h that diminished by 4 h.  It is possible that
the enhanced p38 phosphorylation observed at 4 h is due, in part, to increased acti
of MKK-1/2 and MKK-4.  However, as MKK-3/6 is considered the primary MAP2K 
responsible for activating p38, and because increased activation of MKK-1/2 or MKK-4
is not observed at 4 h, enhanced MAP2K activity may not be  primarily respons
the prolonged activation of TLR-activated, Mn-exposed microglia.  An alternative to 
MAP2K activation of p38 is ‘autophosphorylation’, which requires p38 to associate
the TAK1/TAB1 complex (Ge et al., 2002).  However, we have not examined th
possibility within our experimental model.   
Another mechanism whereby Mn can prolong the activation of p38 is by acti
on the phosphatase MKP-1.  This may be important in the context of Mn-potentiation, a
decreased MKP-1 was observed at 1 h in Mn-exposed cells.  However, by 4 h th
of MKP-1 mRNA and protein had significantly increased relative to controls.  Typical
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preventing prolonged activity of p38 and enhanced expression of inflammatory 








y be that Mn acts ‘downstream’ of the 
initial T
owever the magnitude of the increase was decreased substantially in cells exposed 
to Mn and LPS.  This is in contrast to N9 microglia exposed to Mn, which had less MKP
1 mRNA and protein expression.  Taken together, the initial decrease in MKP-1 
expression could result in enhanced activation of p38.  Furthermore, the delay in ‘no
feedback inhibition may result in increased MKP-1 at a later time point, as the signaling 
pathway within the cell works to deactivate p38.  Indeed, this is what we observed a
for MKP-1 in Mn-exposed cells.  Although the decreased MKP-1 mRNA and protein i
cells exposed to Mn may result in prolonged activation of p38, further examination of 
MKP-1 activation and enzymatic activity is necessary to determine if decreased MKP-1 
expression is responsible for the persistent activation of p38. 
In contrast to the role of the MAPK in Mn-potentiation of IL-6 and TNF-α, 
specific TLR activation is not required for enhanced inflammatory cytokine in the 
presence of Mn.  This is relevant as activation of TLR2, TLR4, and TLR9 are depende
on the adaptor molecule MyD88, while MyD88-independent signaling via TLR3 requires 
TRIF.  Thus, potentiation of inflammatory cytokines by Mn in TLR-activated micro
is not dependent on MyD88 activation.  It ma
LR signaling pathway, suggesting that the MAPK, or another signaling 
pathway(s) intersecting with the MAPK, may be the molecular site of action.   
On the other hand, Mn-potentiation of inflammatory cytokine protein may not be 
due to increased mRNA expression alone.  Activation of the p38 MAPK signaling 
pathway not only increases inflammatory cytokine gene expression, but may also 
 104
promote mRNA stability, resulting in an increased half-life of the cytokine mRN
et al., 2007).  Indeed, p38 phosphorylation of downstream targets like MAPK activated 
kinase-2 (MK-2), as well as tristetraprolin (TTP), is necessary for preventing TNF-α 
mRNA degradation (Sun et al., 2007).  The enhanced p38 activation observed in Mn-
exposed N9 microglia may increase cytokine protein by not only increasing mRN
expression, but also by increasing cytokine message stability. 
    In summary, (i) Mn-potentiation of inflammatory cytokine expression is not 
dependent on microglial activation by a specific TLR, or the TLR adaptor protein 
MyD88, (ii) activation of downstream signaling targets such as p38, ERK, and JNK 
appear to be necessary for enhanced cytokine mRNA and protein expression and (iii) 
increased and prolonged p38 activation partly due to the effects of Mn on MKK-1/2, 
MKK-4, and, importantly, MKP-1, is associated with the pote
A (Sun 
A 








 examination of the MAPK cascade may provide important data in regards to
potentiation of IL-6 and TNF-α.  Specifically, examining alternative p38 activation
mechanisms (i.e. autophosphorylation), as well as the activation of ERK and JNK, may 
indicate the molecular target for Mn-induced inflammatory cytokine potentiation.  
Additionally, examination of the molecular targets of p38, and perhaps ERK and JNK, 
may indicate whether the Mn-potentiation of inflammatory cytokines in TLR-activat
microglia is mainly due to enhanced cytokine mRNA expression and/or to increa
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